BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson JS, Bixler SA, Qian F, Vora K, Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C, Strauch K, Zafari M, Benjamin CD, Tschopp J, Browning JL, Ambrose C. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science. 2001;293:2108-2111. [PMID: 11509692 DOI: 10.1126/science.1061965] [Cited by in Crossref: 664] [Cited by in F6Publishing: 596] [Article Influence: 33.2] [Reference Citation Analysis]
Number Citing Articles
1 Bornacelly A, Mercado D, Acevedo N, Caraballo L. The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF). BMC Immunol 2014;15:22. [PMID: 24906685 DOI: 10.1186/1471-2172-15-22] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
2 Zhang J, Ma H, Sang M, Hu Y, Liang Z, Ai H, Zhang J, Cui X, Zhang S. Molecular structure, expression, cell and tissue distribution, immune evolution and cell proliferation of the gene encoding bovine (Bos taurus) TNFSF13 (APRIL). Developmental & Comparative Immunology 2010;34:1199-208. [DOI: 10.1016/j.dci.2010.06.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
3 Bishton M, Spencer A, Dickinson M, Ritchie D. A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk 2013;13:575-8. [PMID: 23773449 DOI: 10.1016/j.clml.2013.04.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
4 Miosge LA, Blasioli J, Blery M, Goodnow CC. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role of nuclear factor kappaB2 in regulating circulating B cell numbers. J Exp Med 2002;196:1113-9. [PMID: 12391023 DOI: 10.1084/jem.20020959] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
5 Onda K, Iijima K, Katagiri YU, Okita H, Saito M, Shimizu T, Kiyokawa N. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma. Int J Hematol 2010;91:808-19. [PMID: 20428981 DOI: 10.1007/s12185-010-0567-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
6 Hsu BL, Harless SM, Lindsley RC, Hilbert DM, Cancro MP. Cutting Edge: BLyS Enables Survival of Transitional and Mature B Cells Through Distinct Mediators. J Immunol 2002;168:5993-6. [DOI: 10.4049/jimmunol.168.12.5993] [Cited by in Crossref: 235] [Cited by in F6Publishing: 218] [Article Influence: 12.4] [Reference Citation Analysis]
7 Yang S, Li JY, Xu W. Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol Hematol 2014;91:113-22. [PMID: 24629840 DOI: 10.1016/j.critrevonc.2014.02.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
8 Jacob CO, Yu N, Sindhava V, Cancro MP, Pawar RD, Putterman C, Stohl W. Differential Development of Systemic Lupus Erythematosus in NZM 2328 Mice Deficient in Discrete Pairs of BAFF Receptors: DEVELOPMENT OF SLE IN NZM MICE DEFICIENT IN PAIRS OF BAFF RECEPTORS. Arthritis & Rheumatology 2015;67:2523-35. [DOI: 10.1002/art.39210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
9 Zhou X, Xia Z, Lan Q, Wang J, Su W, Han YP, Fan H, Liu Z, Stohl W, Zheng SG. BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis. PLoS One 2011;6:e23629. [PMID: 21897850 DOI: 10.1371/journal.pone.0023629] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
10 Miller JP, Stadanlick JE, Cancro MP. Space, selection, and surveillance: setting boundaries with BLyS. J Immunol 2006;176:6405-10. [PMID: 16709796 DOI: 10.4049/jimmunol.176.11.6405] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 4.8] [Reference Citation Analysis]
11 Yamanishi H, Kumagi T, Yokota T, Azemoto N, Koizumi M, Kobayashi Y, Abe M, Murakami H, Hiasa Y, Matsuura B, Kawamoto H, Yamamoto K, Onji M. Clinical Significance of B Cell-Activating Factor in Autoimmune Pancreatitis. Pancreas 2011;40:840-5. [DOI: 10.1097/mpa.0b013e3182143b10] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 Ch’en PF, Xu X, Liu X, Liu Y, Song C, Screaton GR, Jin B, Xu X. Characterisation of monoclonal antibodies to the TNF and TNF receptor families. Cellular Immunology 2005;236:78-85. [DOI: 10.1016/j.cellimm.2005.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
13 Wang Y, Li YJ, Jiang WQ, Rao HL, Huang JJ, Xia Y, Bi X, Sun P, Huang HQ, Lin TY, Guan ZZ, Li ZM. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP. Ann Hematol 2015;94:1865-73. [PMID: 26327569 DOI: 10.1007/s00277-015-2490-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Rickert RC, Jellusova J, Miletic AV. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol Rev 2011;244:115-33. [PMID: 22017435 DOI: 10.1111/j.1600-065X.2011.01067.x] [Cited by in Crossref: 190] [Cited by in F6Publishing: 117] [Article Influence: 21.1] [Reference Citation Analysis]
15 Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov. 2006;5:235-246. [PMID: 16474316 DOI: 10.1038/nrd1982] [Cited by in Crossref: 224] [Cited by in F6Publishing: 195] [Article Influence: 14.9] [Reference Citation Analysis]
16 Hobeika E, Nielsen PJ, Medgyesi D. Signaling mechanisms regulating B-lymphocyte activation and tolerance. J Mol Med (Berl). 2015;93:143-158. [PMID: 25627575 DOI: 10.1007/s00109-015-1252-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
17 Kim MY, Kim DH, Do MS. B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages. Exp Mol Med 2013;45:e4. [PMID: 23306702 DOI: 10.1038/emm.2013.4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
18 Benson MJ, Elgueta R, Noelle RJ. B cell survival: an unexpected mechanism of lymphocyte vitality. Immunol Cell Biol 2008;86:485-6. [PMID: 18490932 DOI: 10.1038/icb.2008.35] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
19 Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest 2002;109:59-68. [DOI: 10.1172/jci0214121] [Cited by in Crossref: 554] [Article Influence: 29.2] [Reference Citation Analysis]
20 Jordan N, D'Cruz D. Key issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implications. Ther Adv Musculoskelet Dis 2015;7:234-46. [PMID: 26622325 DOI: 10.1177/1759720X15601805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
21 Moura RA, Canhão H, Polido-Pereira J, Rodrigues AM, Navalho M, Mourão AF, Resende C, Campanilho-Marques R, Madruga Dias J, da Silva JA, Graca L, Fonseca JE. BAFF and TACI gene expression are increased in patients with untreated very early rheumatoid arthritis. J Rheumatol 2013;40:1293-302. [PMID: 23772083 DOI: 10.3899/jrheum.121110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
22 Shen X, Zhu W, Zhang X, Xu G, Ju S. A role of both NF-κB pathways in expression and transcription regulation of BAFF-R gene in multiple myeloma cells. Mol Cell Biochem 2011;357:21-30. [PMID: 21607696 DOI: 10.1007/s11010-011-0871-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
23 Levit-Zerdoun E, Becker M, Pohlmeyer R, Wilhelm I, Maity PC, Rajewsky K, Reth M, Hobeika E. Survival of Igα-Deficient Mature B Cells Requires BAFF-R Function. J Immunol 2016;196:2348-60. [PMID: 26843325 DOI: 10.4049/jimmunol.1501707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Garcia-Carmona Y, Ting AT, Radigan L, Athuluri Divakar SK, Chavez J, Meffre E, Cerutti A, Cunningham-Rundles C. TACI Isoforms Regulate Ligand Binding and Receptor Function. Front Immunol 2018;9:2125. [PMID: 30333819 DOI: 10.3389/fimmu.2018.02125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
25 Libbey JE, Peterson LK, Tsunoda I, Fujinami RS. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. J Neuroimmunol 2006;173:135-45. [PMID: 16469392 DOI: 10.1016/j.jneuroim.2005.12.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
26 Nakamura N, Hase H, Sakurai D, Yoshida S, Abe M, Tsukada N, Takizawa J, Aoki S, Kojima M, Nakamura S, Kobata T. Expression of BAFF-R (BR 3) in normal and neoplastic lymphoid tissues characterized with a newly developed monoclonal antibody. Virchows Arch 2005;447:53-60. [PMID: 16025281 DOI: 10.1007/s00428-005-1275-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
27 Edwards JCW, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 2006;6:394-403. [DOI: 10.1038/nri1838] [Cited by in Crossref: 342] [Cited by in F6Publishing: 297] [Article Influence: 22.8] [Reference Citation Analysis]
28 Xu G, Shen XJ, Pu J, Chu SP, Wang XD, Wu XH, Sun CJ, Zhang X, Zhu BL, Ju SQ. BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells. Cytokine 2012;60:505-13. [PMID: 22850273 DOI: 10.1016/j.cyto.2012.06.317] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
29 Jordan NP, D'Cruz DP. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus. Expert Opin Drug Metab Toxicol 2015;11:1635-45. [PMID: 26327145 DOI: 10.1517/17425255.2015.1077808] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109 Suppl:S81-S96. [PMID: 11983155 DOI: 10.1016/s0092-8674(02)00703-1] [Cited by in Crossref: 2703] [Cited by in F6Publishing: 1048] [Article Influence: 142.3] [Reference Citation Analysis]
31 Stohl W. Biologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development? Curr Rheumatol Rep 2012;14:303-9. [PMID: 22547203 DOI: 10.1007/s11926-012-0254-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
32 Sharma A, Kiripolsky J, Klimatcheva E, Howell A, Fereidouni F, Levenson R, Rothstein TL, Kramer JM. Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction. Clin Immunol 2016;164:85-94. [PMID: 26826598 DOI: 10.1016/j.clim.2016.01.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
33 Wang F, Chen L, Ni H, Wang G, Ding W, Cong H, Ju S, Yang S, Wang H. APRIL depletion induces cell cycle arrest and apoptosis through blocking TGF-β1/ERK signaling pathway in human colorectal cancer cells. Mol Cell Biochem 2013;383:179-89. [DOI: 10.1007/s11010-013-1766-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
34 Matsushita T, Fujimoto M, Hasegawa M, Matsushita Y, Komura K, Ogawa F, Watanabe R, Takehara K, Sato S. BAFF Antagonist Attenuates the Development of Skin Fibrosis in Tight-Skin Mice. Journal of Investigative Dermatology 2007;127:2772-80. [DOI: 10.1038/sj.jid.5700919] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
35 Barbosa RR, Silva SL, Silva SP, Melo AC, Pereira-Santos MC, Barata JT, Hammarström L, Cascalho M, Sousa AE. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol 2014;34:573-83. [PMID: 24809296 DOI: 10.1007/s10875-014-0047-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
36 Kolfschoten GM, Pradet-balade B, Hahne M, Medema JP. TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochemical Pharmacology 2003;66:1427-32. [DOI: 10.1016/s0006-2952(03)00493-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
37 Parameswaran R, Müschen M, Kim YM, Groffen J, Heisterkamp N. A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias. Cancer Res 2010;70:4346-56. [PMID: 20460528 DOI: 10.1158/0008-5472.CAN-10-0300] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
38 Jacobs HM, Thouvenel CD, Leach S, Arkatkar T, Metzler G, Scharping NE, Kolhatkar NS, Rawlings DJ, Jackson SW. Cutting Edge: BAFF Promotes Autoantibody Production via TACI-Dependent Activation of Transitional B Cells. J Immunol 2016;196:3525-31. [PMID: 27022196 DOI: 10.4049/jimmunol.1600017] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
39 Kawabata D, Venkatesh J, Ramanujam M, Davidson A, Grimaldi CM, Diamond B. Enhanced selection of high affinity DNA-reactive B cells following cyclophosphamide treatment in mice. PLoS One 2010;5:e8418. [PMID: 20066044 DOI: 10.1371/journal.pone.0008418] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
40 Basha S, Pichichero ME. Decreased TNF family receptor expression on B-cells is associated with reduced humoral responses to Streptococcus pneumoniae infections in young children. Cell Immunol 2017;320:11-9. [PMID: 28947093 DOI: 10.1016/j.cellimm.2017.07.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005;42:763-72. [PMID: 15829264 DOI: 10.1016/j.molimm.2004.06.041] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 6.4] [Reference Citation Analysis]
42 Thangarajh M, Kisiswa L, Pirskanen R, Hillert J. The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis. Scand J Immunol 2007;65:461-6. [PMID: 17444957 DOI: 10.1111/j.1365-3083.2007.01921.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
43 Kim YH, Choi BH, Cheon HG, Do MS. B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation. Exp Mol Med 2009;41:208-16. [PMID: 19293640 DOI: 10.3858/emm.2009.41.3.024] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 3.7] [Reference Citation Analysis]
44 Tsuji-Kawahara S, Chikaishi T, Takeda E, Kato M, Kinoshita S, Kajiwara E, Takamura S, Miyazawa M. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice. J Virol 2010;84:6082-95. [PMID: 20375169 DOI: 10.1128/JVI.02516-09] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
45 Badr G, Borhis G, Lefevre EA, Chaoul N, Deshayes F, Dessirier V, Lapree G, Tsapis A, Richard Y. BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells. Blood 2008;111:2744-54. [PMID: 18172003 DOI: 10.1182/blood-2007-03-081232] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 5.5] [Reference Citation Analysis]
46 Taher TE, Bystrom J, Ong VH, Isenberg DA, Renaudineau Y, Abraham DJ, Mageed RA. Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity. Clin Rev Allergy Immunol 2017;53:237-64. [PMID: 28456914 DOI: 10.1007/s12016-017-8609-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
47 Hancz A, Hérincs Z, Neer Z, Sármay G, Koncz G. Integration of signals mediated by B-cell receptor, B-cell activating factor of the tumor necrosis factor family (BAFF) and Fas (CD95). Immunol Lett 2008;116:211-7. [PMID: 18243342 DOI: 10.1016/j.imlet.2007.12.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
48 Coquery CM, Erickson LD. Regulatory roles of the tumor necrosis factor receptor BCMA. Crit Rev Immunol 2012;32:287-305. [PMID: 23237506 DOI: 10.1615/critrevimmunol.v32.i4.10] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
49 Rolink AG, Melchers F. BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr Opin Immunol 2002;14:266-75. [PMID: 11869903 DOI: 10.1016/s0952-7915(02)00332-1] [Cited by in Crossref: 85] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
50 Ding H, Wang L, Wu X, Yan J, He Y, Ni B, Gao W, Zhong X. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice. J Cell Mol Med 2010;14:1717-25. [PMID: 19627403 DOI: 10.1111/j.1582-4934.2009.00817.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
51 Pelletier M, Thompson JS, Qian F, Bixler SA, Gong D, Cachero T, Gilbride K, Day E, Zafari M, Benjamin C, Gorelik L, Whitty A, Kalled SL, Ambrose C, Hsu Y. Comparison of Soluble Decoy IgG Fusion Proteins of BAFF-R and BCMA as Antagonists for BAFF. Journal of Biological Chemistry 2003;278:33127-33. [DOI: 10.1074/jbc.m305754200] [Cited by in Crossref: 69] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
52 Stohl W. Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE). Expert Review of Clinical Immunology 2017;13:623-33. [DOI: 10.1080/1744666x.2017.1291343] [Cited by in Crossref: 33] [Cited by in F6Publishing: 15] [Article Influence: 8.3] [Reference Citation Analysis]
53 Jackson SW, Davidson A. BAFF inhibition in SLE-Is tolerance restored? Immunol Rev 2019;292:102-19. [PMID: 31562657 DOI: 10.1111/imr.12810] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
54 Yang M, Hase H, Legarda-Addison D, Varughese L, Seed B, Ting AT. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 2005;175:2814-24. [PMID: 16116167 DOI: 10.4049/jimmunol.175.5.2814] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
55 Wu HT, Yan XM, Hu YL, Diao ZY, Wu J, Zhang SQ. Expression, characterization of recombinant human soluble BAFF secreted from CHO cell. Mol Biol 2009;43:76-81. [DOI: 10.1134/s0026893309010105] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Chen C, Ren W, Yang G, Zhang C, Zhang S. Molecular cloning, in vitro expression and bioactivity of quail BAFF. Veterinary Immunology and Immunopathology 2009;130:125-30. [DOI: 10.1016/j.vetimm.2009.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
57 Dan W, Guan Z, Zhang C, Li B, Zhang J, Zhang S. Molecular cloning, in vitro expression and bioactivity of goose B-cell activating factor. Veterinary Immunology and Immunopathology 2007;118:113-20. [DOI: 10.1016/j.vetimm.2007.03.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
58 Chu VT, Enghard P, Schürer S, Steinhauser G, Rudolph B, Riemekasten G, Berek C. Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus. Arthritis Rheum 2009;60:2083-93. [DOI: 10.1002/art.24628] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
59 Kim SS, Richman DP, Zamvil SS, Agius MA. Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice. J Neurol Sci 2011;306:9-15. [PMID: 21529843 DOI: 10.1016/j.jns.2011.04.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
60 O’Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004;199:91-98. [PMID: 14707116 DOI: 10.1084/jem.20031330] [Cited by in Crossref: 668] [Cited by in F6Publishing: 594] [Article Influence: 39.3] [Reference Citation Analysis]
61 Yoshimoto K, Takahashi Y, Ogasawara M, Setoyama Y, Suzuki K, Tsuzaka K, Abe T, Takeuchi T. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy. International Immunology 2006;18:1189-96. [DOI: 10.1093/intimm/dxl053] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
62 Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 2003;14:193-209. [PMID: 12787559 DOI: 10.1016/s1359-6101(03)00021-2] [Cited by in Crossref: 328] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
63 Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, Martin F, Fong S, van Lookeren Campagne M, Godowski P, Williams PM, Chan AC, Clark HF. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005;6:319-31. [DOI: 10.1038/sj.gene.6364173] [Cited by in Crossref: 259] [Cited by in F6Publishing: 218] [Article Influence: 16.2] [Reference Citation Analysis]
64 Kieckens E, Rybarczyk J, Li RW, Vanrompay D, Cox E. Potential immunosuppressive effects of Escherichia coli O157:H7 experimental infection on the bovine host. BMC Genomics 2016;17:1049. [PMID: 28003017 DOI: 10.1186/s12864-016-3374-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
65 Matsushita T, Hasegawa M, Matsushita Y, Echigo T, Wayaku T, Horikawa M, Ogawa F, Takehara K, Sato S. Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases. Exp Dermatol 2007;16:87-93. [DOI: 10.1111/j.1600-0625.2006.00485.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
66 Stohl W. Future prospects in biologic therapy for systemic lupus erythematosus. Nat Rev Rheumatol 2013;9:705-20. [PMID: 24018550 DOI: 10.1038/nrrheum.2013.136] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
67 Chang SK, Arendt BK, Darce JR, Wu X, Jelinek DF. A role for BLyS in the activation of innate immune cells. Blood 2006;108:2687-94. [PMID: 16825497 DOI: 10.1182/blood-2005-12-017319] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
68 Hoek KL, Carlesso G, Clark ES, Khan WN. Absence of mature peripheral B cell populations in mice with concomitant defects in B cell receptor and BAFF-R signaling. J Immunol 2009;183:5630-43. [PMID: 19843948 DOI: 10.4049/jimmunol.0901100] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
69 Allman WR, Liu L, Coleman AS, Akkoyunlu M. MRL Strains Have a BAFFR Mutation without Functional Consequence. PLoS One 2016;11:e0154518. [PMID: 27149280 DOI: 10.1371/journal.pone.0154518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Granger SW, Ware CF. Turning on LIGHT. J Clin Invest 2001;108:1741-2. [PMID: 11748255 DOI: 10.1172/JCI14651] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
71 Baert L, Manfroi B, Casez O, Sturm N, Huard B. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting. Journal of Autoimmunity 2018;95:179-90. [DOI: 10.1016/j.jaut.2018.10.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
72 Wiley SR, Winkles JA. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 2003;14:241-9. [PMID: 12787562 DOI: 10.1016/s1359-6101(03)00019-4] [Cited by in Crossref: 189] [Cited by in F6Publishing: 76] [Article Influence: 11.1] [Reference Citation Analysis]
73 Bossen C, Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin Immunol 2006;18:263-75. [PMID: 16914324 DOI: 10.1016/j.smim.2006.04.006] [Cited by in Crossref: 331] [Cited by in F6Publishing: 271] [Article Influence: 22.1] [Reference Citation Analysis]
74 Auyeung-kim DJ, Devalaraja MN, Migone T, Cai W, Chellman GJ. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reproductive Toxicology 2009;28:443-55. [DOI: 10.1016/j.reprotox.2009.07.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
75 Chan TD, Gardam S, Gatto D, Turner VM, Silke J, Brink R. In vivo control of B-cell survival and antigen-specific B-cell responses. Immunol Rev 2010;237:90-103. [PMID: 20727031 DOI: 10.1111/j.1600-065X.2010.00942.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
76 Koskela K, Nieminen P, Kohonen P, Salminen H, Lassila O. Chicken B-Cell-Activating Factor: Regulator of B-Cell Survival in the Bursa of Fabricius. Scand J Immunol 2004;59:449-57. [DOI: 10.1111/j.0300-9475.2004.01418.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
77 Liu Y, Xu L, Opalka N, Kappler J, Shu H, Zhang G. Crystal Structure of sTALL-1 Reveals a Virus-like Assembly of TNF Family Ligands. Cell 2002;108:383-94. [DOI: 10.1016/s0092-8674(02)00631-1] [Cited by in Crossref: 143] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
78 Opferman JT. Apoptosis in the development of the immune system. Cell Death Differ 2008;15:234-42. [DOI: 10.1038/sj.cdd.4402182] [Cited by in Crossref: 76] [Cited by in F6Publishing: 65] [Article Influence: 5.4] [Reference Citation Analysis]
79 Zhao Y, Zhang W, Liu Y, Wang Z, Yuan Y. Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies. Orphanet J Rare Dis 2020;15:181. [PMID: 32641139 DOI: 10.1186/s13023-020-01431-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2:465-475. [PMID: 12094221 DOI: 10.1038/nri844] [Cited by in Crossref: 467] [Cited by in F6Publishing: 413] [Article Influence: 24.6] [Reference Citation Analysis]
81 Gandhi KS, McKay FC, Schibeci SD, Arthur JW, Heard RN, Stewart GJ, Booth DR. BAFF is a biological response marker to IFN-beta treatment in multiple sclerosis. J Interferon Cytokine Res 2008;28:529-39. [PMID: 18715196 DOI: 10.1089/jir.2008.0007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
82 Rossi JF. Phase I study of atacicept in relapsed/refractory multiple myeloma (MM) and Waldenström's macroglobulinemia. Clin Lymphoma Myeloma Leuk 2011;11:136-8. [PMID: 21454215 DOI: 10.3816/CLML.2011.n.031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
83 You F, Ren W, Hou H, Pei L, He Z. Molecular cloning, expression, bioinformatics analysis and bioactivity characterization of TNF13B (BAFF) gene in bat (Vespertilio superans Thomas). International Immunopharmacology 2012;12:433-40. [DOI: 10.1016/j.intimp.2011.12.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
84 Hildebrand JM, Luo Z, Manske MK, Price-Troska T, Ziesmer SC, Lin W, Hostager BS, Slager SL, Witzig TE, Ansell SM, Cerhan JR, Bishop GA, Novak AJ. A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J Exp Med 2010;207:2569-79. [PMID: 21041452 DOI: 10.1084/jem.20100857] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
85 Wang H, Clarke SH. Positive selection focuses the VH12 B-cell repertoire towards a single B1 specificity with survival function. Immunol Rev 2004;197:51-9. [DOI: 10.1111/j.0105-2896.2004.0098.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
86 Davidson A, Wang X, Mihara M, Ramanujam M, Huang W, Schiffer L, Sinha J. Co-Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE). Annals of the New York Academy of Sciences 2003;987:188-98. [DOI: 10.1111/j.1749-6632.2003.tb06048.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
87 Ai H, Shen Y, Min C, Pang S, Zhang J, Zhang S, Zhao Z. Molecular structure, expression and bioactivity characterization of TNF13B (BAFF) gene in mefugu, Takifugu obscurus. Fish Shellfish Immunol 2011;30:1265-74. [PMID: 21463693 DOI: 10.1016/j.fsi.2011.03.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
88 Mori S, Kubo S, Akiyoshi T, Yamada S, Miyazaki T, Hotta H, Desaki J, Kishi M, Konishi T, Nishino Y, Miyazawa A, Maruyama N, Shigemoto K. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis. Am J Pathol 2012;180:798-810. [PMID: 22142810 DOI: 10.1016/j.ajpath.2011.10.031] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
89 Huard B, McKee T, Bosshard C, Durual S, Matthes T, Myit S, Donze O, Frossard C, Chizzolini C, Favre C, Zubler R, Guyot JP, Schneider P, Roosnek E. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest 2008;118:2887-95. [PMID: 18618015 DOI: 10.1172/JCI33760] [Cited by in Crossref: 31] [Cited by in F6Publishing: 74] [Article Influence: 2.4] [Reference Citation Analysis]
90 Lesley R, Xu Y, Kalled SL, Hess DM, Schwab SR, Shu HB, Cyster JG. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity 2004;20:441-53. [PMID: 15084273 DOI: 10.1016/s1074-7613(04)00079-2] [Cited by in Crossref: 423] [Cited by in F6Publishing: 222] [Article Influence: 24.9] [Reference Citation Analysis]
91 Paiano J, Harland M, Strainic MG, Nedrud J, Hussain W, Medof ME. Follicular B2 Cell Activation and Class Switch Recombination Depend on Autocrine C3ar1/C5ar1 Signaling in B2 Cells. J Immunol 2019;203:379-88. [PMID: 31217324 DOI: 10.4049/jimmunol.1900276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
92 He B, Raab-Traub N, Casali P, Cerutti A. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching. J Immunol 2003;171:5215-24. [PMID: 14607922 DOI: 10.4049/jimmunol.171.10.5215] [Cited by in Crossref: 169] [Cited by in F6Publishing: 148] [Article Influence: 9.9] [Reference Citation Analysis]
93 Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets 2020;24:1135-45. [PMID: 32900236 DOI: 10.1080/14728222.2020.1821647] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
94 Edner NM, Carlesso G, Rush JS, Walker LSK. Targeting co-stimulatory molecules in autoimmune disease. Nat Rev Drug Discov 2020;19:860-83. [PMID: 32939077 DOI: 10.1038/s41573-020-0081-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
95 Novak AJ, Grote DM, Stenson M, Ziesmer SC, Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF, Gross JA, Ansell SM. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004;104:2247-53. [PMID: 15251985 DOI: 10.1182/blood-2004-02-0762] [Cited by in Crossref: 167] [Cited by in F6Publishing: 141] [Article Influence: 9.8] [Reference Citation Analysis]
96 Goto T, Bandoh N, Yoshizaki T, Nozawa H, Takahara M, Ueda S, Hayashi T, Harabuchi Y. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy. Clin Immunol 2008;126:260-9. [PMID: 18249037 DOI: 10.1016/j.clim.2007.11.003] [Cited by in F6Publishing: 35] [Reference Citation Analysis]
97 Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002;27:19-26. [PMID: 11796220 DOI: 10.1016/s0968-0004(01)01995-8] [Cited by in Crossref: 580] [Cited by in F6Publishing: 209] [Article Influence: 30.5] [Reference Citation Analysis]
98 Khlaiphuengsin A, Chuaypen N, Sodsai P, Buranapraditkun S, Boonpiyathad T, Hirankarn N, Tangkijvanich P. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2020;26:2645-56. [PMID: 32523317 DOI: 10.3748/wjg.v26.i20.2645] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
99 Tumanov AV, Kuprash DV, Nedospasov SA. The role of lymphotoxin in development and maintenance of secondary lymphoid tissues. Cytokine & Growth Factor Reviews 2003;14:275-88. [DOI: 10.1016/s1359-6101(03)00026-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
100 Avery DT, Kalled SL, Ellyard JI, Ambrose C, Bixler SA, Thien M, Brink R, Mackay F, Hodgkin PD, Tangye SG. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 2003;112:286-97. [PMID: 12865416 DOI: 10.1172/JCI18025] [Cited by in Crossref: 281] [Cited by in F6Publishing: 147] [Article Influence: 15.6] [Reference Citation Analysis]
101 Deng BP, Zhang Y, Wang QJ, Xu XF, Zhang H, Yang YM, Mao HT, Gao WJ, Song BF, Kong BH, Qu X. Soluble BAFF-R produced by decidual stromal cells plays an inhibitory role in monocytes and macrophages. Reprod Biomed Online 2012;24:654-63. [PMID: 22503273 DOI: 10.1016/j.rbmo.2012.02.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
102 Yang K, Xiao K, Huang H, Lu S, Zhong J, Ansari AR, Khaliq H, Song H, Liu H, Peng K. Molecular cloning, expression and bioactivity of B cell activating factor (BAFF) in African ostrich. International Immunopharmacology 2015;28:686-94. [DOI: 10.1016/j.intimp.2015.07.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
103 Schaller M, Studt J, Voorberg J, Hovinga JA. Acquired thrombotic thrombocytopenic purpura: Development of an autoimmune response. Hamostaseologie 2018;33:121-30. [DOI: 10.5482/hamo-12-12-0023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
104 Bellucci R, Alyea EP, Chiaretti S, Wu CJ, Zorn E, Weller E, Wu B, Canning C, Schlossman R, Munshi NC, Anderson KC, Ritz J. Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor. Blood 2005;105:3945-50. [PMID: 15692072 DOI: 10.1182/blood-2004-11-4463] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
105 Boghdadi G, Elewa EA. Increased serum APRIL differentially correlates with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients. Rheumatol Int 2014;34:1217-23. [PMID: 24748505 DOI: 10.1007/s00296-014-3020-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
106 He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 2004;172:3268-79. [PMID: 14978135 DOI: 10.4049/jimmunol.172.5.3268] [Cited by in Crossref: 210] [Cited by in F6Publishing: 180] [Article Influence: 12.4] [Reference Citation Analysis]
107 Xie P, Stunz LL, Larison KD, Yang B, Bishop GA. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 2007;27:253-67. [PMID: 17723217 DOI: 10.1016/j.immuni.2007.07.012] [Cited by in Crossref: 149] [Cited by in F6Publishing: 143] [Article Influence: 10.6] [Reference Citation Analysis]
108 Stohl W. SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder. Arthritis Res Ther 2003;5:136-8. [PMID: 12723979 DOI: 10.1186/ar755] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
109 Gatto D, Ruedl C, Odermatt B, Bachmann MF. Rapid Response of Marginal Zone B Cells to Viral Particles. J Immunol 2004;173:4308-16. [DOI: 10.4049/jimmunol.173.7.4308] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
110 Fragioudaki M, Boula A, Tsirakis G, Psarakis F, Spanoudakis M, Papadakis IS, Pappa CA, Alexandrakis MG. B cell-activating factor: its clinical significance in multiple myeloma patients. Ann Hematol 2012;91:1413-8. [PMID: 22526370 DOI: 10.1007/s00277-012-1470-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
111 Trescol-Biémont MC, Verschelde C, Cottalorda A, Bonnefoy-Bérard N. Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Biochimie 2004;86:287-94. [PMID: 15194232 DOI: 10.1016/j.biochi.2004.04.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
112 Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Dig Dis Sci 2016;61:3407-24. [PMID: 27655102 DOI: 10.1007/s10620-016-4317-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
113 Gautam US, McGillivray A, Mehra S, Didier PJ, Midkiff CC, Kissee RS, Golden NA, Alvarez X, Niu T, Rengarajan J, Sherman DR, Kaushal D. DosS Is required for the complete virulence of mycobacterium tuberculosis in mice with classical granulomatous lesions. Am J Respir Cell Mol Biol 2015;52:708-16. [PMID: 25322074 DOI: 10.1165/rcmb.2014-0230OC] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
114 Novak AJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood. 2002;100:2973-2979. [PMID: 12351410 DOI: 10.1182/blood-2002-02-0558] [Cited by in Crossref: 173] [Cited by in F6Publishing: 156] [Article Influence: 9.1] [Reference Citation Analysis]
115 Wise LM, Stohl W. Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents. Front Med (Lausanne) 2020;7:303. [PMID: 32695790 DOI: 10.3389/fmed.2020.00303] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
116 Zhao LD, Li Y, Smith MF Jr, Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X. Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 2010;19:1534-49. [PMID: 20974656 DOI: 10.1177/0961203310375268] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
117 Langat DL, Wheaton DA, Platt JS, Sifers T, Hunt JS. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta. Am J Pathol 2008;172:1303-11. [PMID: 18403603 DOI: 10.2353/ajpath.2008.071139] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
118 Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 2004;21:629-42. [PMID: 15539150 DOI: 10.1016/j.immuni.2004.09.011] [Cited by in Crossref: 164] [Cited by in F6Publishing: 162] [Article Influence: 9.6] [Reference Citation Analysis]
119 Horst AK, Kumashie KG, Neumann K, Diehl L, Tiegs G. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease. Cell Mol Immunol 2021;18:92-111. [PMID: 33110250 DOI: 10.1038/s41423-020-00568-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
120 Roosnek E, Burjanadze M, Dietrich P, Matthes T, Passweg J, Huard B. Tumors that look for their springtime in APRIL. Critical Reviews in Oncology/Hematology 2009;72:91-7. [DOI: 10.1016/j.critrevonc.2009.01.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
121 Chae SC, Yu JI, Oh GJ, Choi CS, Choi SC, Yang YS, Yun KJ. Identification of single nucleotide polymorphisms in the TNFRSF17 gene and their association with gastrointestinal disorders. Mol Cells. 2010;29:21-28. [PMID: 20016944 DOI: 10.1007/s10059-010-0002-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
122 Cerutti A. The regulation of IgA class switching. Nat Rev Immunol. 2008;8:421-434. [PMID: 18483500 DOI: 10.1038/nri2322] [Cited by in Crossref: 412] [Cited by in F6Publishing: 359] [Article Influence: 31.7] [Reference Citation Analysis]
123 Lin Z, Dan-Rong Y, Xiao-Qing T, Hao W, Hong-Lian G, Xian-Tao K, Ren-Qian Z, Jiyu L. Preliminary clinical measurement of the expression of B-cell activating factor in Chinese systemic lupus erythematosus patients. J Clin Lab Anal 2007;21:183-7. [PMID: 17506477 DOI: 10.1002/jcla.20161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
124 Grant JR, Moise AR, Jefferies WA. Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI. Clin Vaccine Immunol 2007;14:907-17. [PMID: 17538121 DOI: 10.1128/CVI.00058-07] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Ahn S, Cunningham-Rundles C. Role of B cells in common variable immune deficiency. Expert Rev Clin Immunol 2009;5:557-64. [PMID: 20477641 DOI: 10.1586/eci.09.43] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
126 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109:1587-1598. [PMID: 12070306 DOI: 10.1172/jci0215034] [Cited by in Crossref: 168] [Article Influence: 8.8] [Reference Citation Analysis]
127 Saunders A, Webb LMC, Janas ML, Hutchings A, Pascall J, Carter C, Pugh N, Morgan G, Turner M, Butcher GW. Putative GTPase GIMAP1 is critical for the development of mature B and T lymphocytes. Blood 2010;115:3249-57. [DOI: 10.1182/blood-2009-08-237586] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
128 You F, Ren W, Gu S, Wang W, Zhou L, Zhang Y, Gan W, Chen M. First BAFF gene cloned from an aquatic mammal. Gene 2012;504:13-21. [DOI: 10.1016/j.gene.2012.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
129 Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol. 2005;17:282-289. [PMID: 15886118 DOI: 10.1016/j.coi.2005.04.005] [Cited by in Crossref: 251] [Cited by in F6Publishing: 221] [Article Influence: 15.7] [Reference Citation Analysis]
130 Samardzic T, Marinkovic D, Nielsen PJ, Nitschke L, Wirth T. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol Cell Biol 2002;22:8320-31. [PMID: 12417733 DOI: 10.1128/MCB.22.23.8320-8331.2002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
131 Schneider P, Olson D, Tardivel A, Browning B, Lugovskoy A, Gong D, Dobles M, Hertig S, Hofmann K, Van Vlijmen H, Hsu Y, Burkly LC, Tschopp J, Zheng TS. Identification of a New Murine Tumor Necrosis Factor Receptor Locus That Contains Two Novel Murine Receptors for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL). Journal of Biological Chemistry 2003;278:5444-54. [DOI: 10.1074/jbc.m210783200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 49] [Article Influence: 4.8] [Reference Citation Analysis]
132 Park YW, Pryshchep S, Seyler TM, Goronzy JJ, Weyand CM. B cells as a therapeutic target in autoimmune diseases. Expert Opinion on Therapeutic Targets 2005;9:431-45. [DOI: 10.1517/14728222.9.3.431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
133 Woodland RT, Schmidt MR, Thompson CB. BLyS and B cell homeostasis. Semin Immunol 2006;18:318-26. [PMID: 16931037 DOI: 10.1016/j.smim.2006.06.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
134 Masuda K, Davis RS, Maruyama T, Zhang J, He T, Cooper MD, O-Wang J, Burrows PD. FcRY, an Fc receptor related gene differentially expressed during B lymphocyte development and activation. Gene 2005;363:32-40. [PMID: 16263223 DOI: 10.1016/j.gene.2005.08.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
135 Tran NL, Schneider P, Santiago-raber M. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus. Eur J Immunol 2017;47:713-23. [DOI: 10.1002/eji.201646630] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
136 Mayne CG, Amanna IJ, Nashold FE, Hayes CE. Systemic autoimmunity in BAFF-R-mutant A/WySnJ strain mice. Eur J Immunol 2008;38:587-98. [PMID: 18200501 DOI: 10.1002/eji.200737817] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
137 Brightbill HD, Jackman JK, Suto E, Kennedy H, Jones C 3rd, Chalasani S, Lin Z, Tam L, Roose-Girma M, Balazs M, Austin CD, Lee WP, Wu LC. Conditional Deletion of NF-κB-Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation. J Immunol 2015;195:953-64. [PMID: 26116508 DOI: 10.4049/jimmunol.1401514] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
138 Srivastava B, Lindsley RC, Nikbakht N, Allman D. Models for peripheral B cell development and homeostasis. Semin Immunol 2005;17:175-82. [PMID: 15826822 DOI: 10.1016/j.smim.2005.02.008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
139 Petri M, Stohl W, Chatham W, Mccune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis Rheum 2008;58:2453-9. [DOI: 10.1002/art.23678] [Cited by in Crossref: 267] [Cited by in F6Publishing: 234] [Article Influence: 20.5] [Reference Citation Analysis]
140 Kimberley FC, Medema JP, Hahne M. APRIL in B-cell Malignancies and Autoimmunity. In: Kalthoff H, editor. Death Receptors and Cognate Ligands in Cancer. Berlin: Springer Berlin Heidelberg; 2009. pp. 161-82. [DOI: 10.1007/400_2008_19] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
141 Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004;173:2245-52. [PMID: 15294936 DOI: 10.4049/jimmunol.173.4.2245] [Cited by in Crossref: 270] [Cited by in F6Publishing: 255] [Article Influence: 15.9] [Reference Citation Analysis]
142 Phillips TA, Ni J, Hunt JS. Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas. Journal of Leukocyte Biology 2003;74:81-7. [DOI: 10.1189/jlb.0103033] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
143 Cancro MP. The BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation. Immunol Rev 2004;202:237-49. [PMID: 15546397 DOI: 10.1111/j.0105-2896.2004.00212.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
144 Au PY, Yeh WC. Physiological roles and mechanisms of signaling by TRAF2 and TRAF5. Adv Exp Med Biol 2007;597:32-47. [PMID: 17633015 DOI: 10.1007/978-0-387-70630-6_3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
145 Laird MW, Sampey GC, Johnson K, Zukauskas D, Pierre J, Hong JS, Cooksey BA, Li Y, Galperina O, Karwoski JD, Burke RN. Optimization of BLyS production and purification from Escherichia coli. Protein Expression and Purification 2005;39:237-46. [DOI: 10.1016/j.pep.2004.10.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
146 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest 2002;109:1587-98. [PMID: 12070306 DOI: 10.1172/JCI15034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 71] [Article Influence: 0.3] [Reference Citation Analysis]
147 Rodríguez-Carrio J, Alperi-López M, López P, Ballina-García FJ, Suárez A. Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes. Front Immunol 2018;9:2351. [PMID: 30369929 DOI: 10.3389/fimmu.2018.02351] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
148 Bath NM, Ding X, Wilson NA, Verhoven BM, Boldt BA, Sukhwal A, Reese SR, Panzer SE, Djamali A, Redfield RR 3rd. Desensitization and treatment with APRIL/BLyS blockade in rodent kidney transplant model. PLoS One 2019;14:e0211865. [PMID: 30735519 DOI: 10.1371/journal.pone.0211865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
149 Patke A, Mecklenbräuker I, Tarakhovsky A. Survival signaling in resting B cells. Current Opinion in Immunology 2004;16:251-5. [DOI: 10.1016/j.coi.2004.01.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
150 Wang ZZ, Song J, Wang H, Li JX, Xiao Q, Yu Z, Liu JX, Liu Z. B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps. Front Immunol 2020;11:625630. [PMID: 33552090 DOI: 10.3389/fimmu.2020.625630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Santiago ML, Smith DS, Barrett BS, Montano M, Benitez RL, Pelanda R, Hasenkrug KJ, Greene WC. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor. J Virol 2011;85:189-99. [PMID: 20980520 DOI: 10.1128/JVI.01838-10] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
152 Maia S, Pelletier M, Ding J, Hsu YM, Sallan SE, Rao SP, Nadler LM, Cardoso AA. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival. PLoS One. 2011;6:e20787. [PMID: 21687682 DOI: 10.1371/journal.pone.0020787] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
153 Stohl W, Jacob N, Quinn WJ 3rd, Cancro MP, Gao H, Putterman C, Gao X, Pricop L, Koss MN. Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol 2008;181:833-41. [PMID: 18566449 DOI: 10.4049/jimmunol.181.1.833] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
154 Kayagaki N, Yan M, Seshasayee D, Wang H, Lee W, French DM, Grewal IS, Cochran AG, Gordon NC, Yin J. BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. Immunity. 2002;17:515-524. [PMID: 12387744 DOI: 10.1016/S1074-7613(02)00425-9] [Cited by in Crossref: 352] [Cited by in F6Publishing: 130] [Article Influence: 18.5] [Reference Citation Analysis]
155 Rahman ZS, Rao SP, Kalled SL, Manser T. Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med. 2003;198:1157-1169. [PMID: 14557413 DOI: 10.1084/jem.20030495] [Cited by in Crossref: 172] [Cited by in F6Publishing: 162] [Article Influence: 9.6] [Reference Citation Analysis]
156 Jung DJ, Bong JJ, Baik M. Extracellular proteinase inhibitor-accelerated apoptosis is associated with B cell activating factor in mammary epithelial cells. Experimental Cell Research 2004;292:115-22. [DOI: 10.1016/j.yexcr.2003.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
157 Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R. Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches. Immunity 2004;20:785-98. [DOI: 10.1016/j.immuni.2004.05.010] [Cited by in Crossref: 517] [Cited by in F6Publishing: 478] [Article Influence: 30.4] [Reference Citation Analysis]
158 Schneider P, Tschopp J. BAFF and the regulation of B cell survival. Immunol Lett 2003;88:57-62. [PMID: 12853163 DOI: 10.1016/s0165-2478(03)00050-6] [Cited by in Crossref: 69] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
159 Schiffer LE, Hussain N, Wang X, Huang W, Sinha J, Ramanujam M, Davidson A. Lowering anti-dsDNA antibodies--what's new? Lupus 2002;11:885-94. [PMID: 12529055 DOI: 10.1191/0961203302lu311rr] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
160 Huard B, Tran NL, Benkhoucha M, Manzin-Lorenzi C, Santiago-Raber ML. Selective APRIL blockade delays systemic lupus erythematosus in mouse. PLoS One 2012;7:e31837. [PMID: 22355399 DOI: 10.1371/journal.pone.0031837] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
161 Shin W, Lee HT, Lim H, Lee SH, Son JY, Lee JU, Yoo KY, Ryu SE, Rhie J, Lee JY, Heo YS. BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus. Nat Commun 2018;9:1200. [PMID: 29572471 DOI: 10.1038/s41467-018-03620-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
162 Patke A, Mecklenbräuker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006;203:2551-62. [PMID: 17060474 DOI: 10.1084/jem.20060990] [Cited by in Crossref: 146] [Cited by in F6Publishing: 140] [Article Influence: 9.7] [Reference Citation Analysis]
163 Sakai J, Akkoyunlu M. The Role of BAFF System Molecules in Host Response to Pathogens. Clin Microbiol Rev 2017;30:991-1014. [PMID: 28855265 DOI: 10.1128/CMR.00046-17] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 8.8] [Reference Citation Analysis]
164 Sutherland AP, Mackay F, Mackay CR. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas. Pharmacology & Therapeutics 2006;112:774-86. [DOI: 10.1016/j.pharmthera.2006.06.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
165 Losi CG, Silini A, Fiorini C, Soresina A, Meini A, Ferrari S, Notarangelo LD, Lougaris V, Plebani A. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 2005;25:496-502. [PMID: 16160919 DOI: 10.1007/s10875-005-5637-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]
166 Stohl W. B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr Rheumatol Rep 2002;4:345-50. [PMID: 12126587 DOI: 10.1007/s11926-002-0044-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
167 Zhou L, Zhong R, Hao W, Wang H, Fan X, Zhang L, Mi Q. Interleukin-10 and interferon-gamma up-regulate the expression of B-cell activating factor in cultured human promyelocytic leukemia cells. Exp Mol Pathol 2009;87:54-8. [PMID: 19393234 DOI: 10.1016/j.yexmp.2009.04.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
168 Ogden CA, Pound JD, Batth BK, Owens S, Johannessen I, Wood K, Gregory CD. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. J Immunol 2005;174:3015-23. [PMID: 15728515 DOI: 10.4049/jimmunol.174.5.3015] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 6.2] [Reference Citation Analysis]
169 Cancro MP. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev 2004;197:89-101. [DOI: 10.1111/j.0105-2896.2004.0099.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
170 Roundy KM, Jacobson AC, Weis JJ, Weis JH. The in vitro derivation of phenotypically mature and diverse B cells from immature spleen and bone marrow precursors. Eur J Immunol 2010;40:1139-49. [PMID: 20077404 DOI: 10.1002/eji.200939661] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
171 Zhang P, Liu X, Guo A, Xiong J, Fu Y, Zou K. B Cell-Activating Factor as a New Potential Marker in Inflammatory Bowel Disease. Dig Dis Sci 2016;61:2608-18. [DOI: 10.1007/s10620-016-4136-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
172 Heremans J, Garcia-perez JE, Turro E, Schlenner SM, Casteels I, Collin R, de Zegher F, Greene D, Humblet-baron S, Lesage S, Matthys P, Penkett CJ, Put K, Stirrups K, Thys C, Van Geet C, Van Nieuwenhove E, Wouters C, Meyts I, Freson K, Liston A. Abnormal differentiation of B cells and megakaryocytes in patients with Roifman syndrome. Journal of Allergy and Clinical Immunology 2018;142:630-46. [DOI: 10.1016/j.jaci.2017.11.061] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
173 Ng LG, Sutherland AP, Newton R, Qian F, Cachero TG, Scott ML, Thompson JS, Wheway J, Chtanova T, Groom J, Sutton IJ, Xin C, Tangye SG, Kalled SL, Mackay F, Mackay CR. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004;173:807-817. [PMID: 15240667 DOI: 10.4049/jimmunol.173.2.807] [Cited by in Crossref: 339] [Cited by in F6Publishing: 317] [Article Influence: 19.9] [Reference Citation Analysis]
174 Shimomura Y, Ogawa A, Kawada M, Sugimoto K, Mizoguchi E, Shi HN, Pillai S, Bhan AK, Mizoguchi A. A unique B2 B cell subset in the intestine. J Exp Med 2008;205:1343-55. [PMID: 18519649 DOI: 10.1084/jem.20071572] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
175 Day ES, Cote SM, Whitty A. Binding efficiency of protein-protein complexes. Biochemistry 2012;51:9124-36. [PMID: 23088250 DOI: 10.1021/bi301039t] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
176 Calame KL. Plasma cells: finding new light at the end of B cell development. Nat Immunol 2001;2:1103-8. [DOI: 10.1038/ni1201-1103] [Cited by in Crossref: 198] [Cited by in F6Publishing: 168] [Article Influence: 9.9] [Reference Citation Analysis]
177 Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome. J Clin Invest. 2002;109:59-68. [PMID: 11781351 DOI: 10.1172/jci14121] [Cited by in Crossref: 15] [Cited by in F6Publishing: 232] [Article Influence: 0.8] [Reference Citation Analysis]
178 Cunningham-rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nat Rev Immunol 2005;5:880-92. [DOI: 10.1038/nri1713] [Cited by in Crossref: 109] [Cited by in F6Publishing: 86] [Article Influence: 6.8] [Reference Citation Analysis]
179 Tangye SG, Bryant VL, Cuss AK, Good KL. BAFF, APRIL and human B cell disorders. Semin Immunol 2006;18:305-17. [PMID: 16916610 DOI: 10.1016/j.smim.2006.04.004] [Cited by in Crossref: 149] [Cited by in F6Publishing: 126] [Article Influence: 9.9] [Reference Citation Analysis]
180 Chu VT, Enghard P, Riemekasten G, Berek C. In vitro and in vivo activation induces BAFF and APRIL expression in B cells. J Immunol 2007;179:5947-57. [PMID: 17947668 DOI: 10.4049/jimmunol.179.9.5947] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 6.6] [Reference Citation Analysis]
181 Ding W, Ju S, Jiang S, Zhu L, Wang Y, Wang H. Reduced APRIL Expression Induces Cellular Senescence via a HSPG-Dependent Pathway. Pathol Oncol Res 2009;15:693-701. [DOI: 10.1007/s12253-009-9172-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
182 Lenert P. Inhibitory oligodeoxynucleotides - therapeutic promise for systemic autoimmune diseases? Clin Exp Immunol 2005;140:1-10. [PMID: 15762869 DOI: 10.1111/j.1365-2249.2004.02728.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
183 Rossi JF, Moreaux J, Hose D, Requirand G, Rose M, Rouillé V, Nestorov I, Mordenti G, Goldschmidt H, Ythier A, Klein B. Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study. Br J Cancer 2009;101:1051-8. [PMID: 19789533 DOI: 10.1038/sj.bjc.6605241] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
184 Wu DH, Xu L, Wen CP, Xie GQ, Ji JJ, Pan JL, Jiao YF, Fan YS. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway. PLoS One 2015;10:e0118462. [PMID: 25689512 DOI: 10.1371/journal.pone.0118462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
185 Ouyang W, Yu Z, Zhao X, Lu S, Wang Z. Aptamers in hematological malignancies and their potential therapeutic implications. Crit Rev Oncol Hematol 2016;106:108-17. [PMID: 27637356 DOI: 10.1016/j.critrevonc.2016.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
186 Durandy A, Taubenheim N, Peron S, Fischer A. Pathophysiology of B‐Cell Intrinsic Immunoglobulin Class Switch Recombination Deficiencies. AID for Immunoglobulin Diversity. Elsevier; 2007. pp. 275-306. [DOI: 10.1016/s0065-2776(06)94009-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
187 Kil LP, Hendriks RW. Aberrant B cell selection and activation in systemic lupus erythematosus. Int Rev Immunol 2013;32:445-70. [PMID: 23768157 DOI: 10.3109/08830185.2013.786712] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
188 Kimberley FC, van Bostelen L, Cameron K, Hardenberg G, Marquart JA, Hahne M, Medema JP. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J 2009;23:1584-95. [PMID: 19141538 DOI: 10.1096/fj.08-124669] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
189 Henderson RB, Grys K, Vehlow A, de Bettignies C, Zachacz A, Henley T, Turner M, Batista F, Tybulewicz VL. A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival. J Exp Med 2010;207:837-53. [PMID: 20308364 DOI: 10.1084/jem.20091489] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
190 Fairfax K, Mackay IR, Mackay F. BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. IUBMB Life 2012;64:595-602. [PMID: 22641424 DOI: 10.1002/iub.1046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
191 Baker KP, Edwards BM, Main SH, Choi GH, Wager RE, Halpern WG, Lappin PB, Riccobene T, Abramian D, Sekut L, Sturm B, Poortman C, Minter RR, Dobson CL, Williams E, Carmen S, Smith R, Roschke V, Hilbert DM, Vaughan TJ, Albert VR. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis & Rheumatism 2003;48:3253-65. [DOI: 10.1002/art.11299] [Cited by in Crossref: 323] [Cited by in F6Publishing: 276] [Article Influence: 17.9] [Reference Citation Analysis]
192 Bergbreiter A, Salzer U. Common variable immunodeficiency: a multifaceted and puzzling disorder. Expert Review of Clinical Immunology 2014;5:167-80. [DOI: 10.1586/1744666x.5.2.167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
193 Acosta-Rodríguez EV, Craxton A, Hendricks DW, Merino MC, Montes CL, Clark EA, Gruppi A. BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol 2007;37:990-1000. [PMID: 17357108 DOI: 10.1002/eji.200636698] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
194 Hase H, Kanno Y, Kojima M, Hasegawa K, Sakurai D, Kojima H, Tsuchiya N, Tokunaga K, Masawa N, Azuma M, Okumura K, Kobata T. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 2004;103:2257-65. [DOI: 10.1182/blood-2003-08-2694] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 6.5] [Reference Citation Analysis]
195 Tezuka H, Abe Y, Asano J, Sato T, Liu J, Iwata M, Ohteki T. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity. 2011;34:247-257. [PMID: 21333555 DOI: 10.1016/j.immuni.2011.02.002] [Cited by in Crossref: 151] [Cited by in F6Publishing: 135] [Article Influence: 15.1] [Reference Citation Analysis]
196 Qin H, Dong Z, Wang X, Cheng WA, Wen F, Xue W, Sun H, Walter M, Wei G, Smith DL, Sun X, Fei F, Xie J, Panagopoulou TI, Chen CW, Song JY, Aldoss I, Kayembe C, Sarno L, Müschen M, Inghirami GG, Forman SJ, Kwak LW. CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies. Sci Transl Med 2019;11:eaaw9414. [PMID: 31554741 DOI: 10.1126/scitranslmed.aaw9414] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 25.0] [Reference Citation Analysis]
197 Nardelli B, Moore PA, Li Y, Hilbert DM. B Lymphocyte Stimulator (BLyS): A Therapeutic Trichotomy for the Treatment of B Lymphocyte Diseases. Leukemia & Lymphoma 2009;43:1367-73. [DOI: 10.1080/10428190290033297] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
198 Boothby MR, Hodges E, Thomas JW. Molecular regulation of peripheral B cells and their progeny in immunity. Genes Dev 2019;33:26-48. [PMID: 30602439 DOI: 10.1101/gad.320192.118] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
199 Qian Y, Giltiay N, Xiao J, Wang Y, Tian J, Han S, Scott M, Carter R, Jorgensen TN, Li X. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjögren's syndrome. Eur J Immunol 2008;38:2219-28. [PMID: 18624351 DOI: 10.1002/eji.200738113] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.0] [Reference Citation Analysis]
200 Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis 2003;62:168-71. [PMID: 12525388 DOI: 10.1136/ard.62.2.168] [Cited by in Crossref: 390] [Cited by in F6Publishing: 346] [Article Influence: 21.7] [Reference Citation Analysis]
201 Eibel H, Kraus H, Sic H, Kienzler AK, Rizzi M. B cell biology: an overview. Curr Allergy Asthma Rep 2014;14:434. [PMID: 24633618 DOI: 10.1007/s11882-014-0434-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
202 Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Clinical Biochemistry 2006;39:1131-7. [DOI: 10.1016/j.clinbiochem.2006.09.010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
203 Hobeika E, Dautzenberg M, Levit-Zerdoun E, Pelanda R, Reth M. Conditional Selection of B Cells in Mice With an Inducible B Cell Development. Front Immunol 2018;9:1806. [PMID: 30127788 DOI: 10.3389/fimmu.2018.01806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
204 Daridon C, Youinou P, Pers J. BAFF, APRIL, TWE-PRIL: Who's who? Autoimmunity Reviews 2008;7:267-71. [DOI: 10.1016/j.autrev.2007.05.002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
205 Amanna IJ, Clise-dwyer K, Nashold FE, Hoag KA, Hayes CE. Cutting Edge: A/WySnJ Transitional B Cells Overexpress the Chromosome 15 Proapoptotic Blk Gene and Succumb to Premature Apoptosis. J Immunol 2001;167:6069-72. [DOI: 10.4049/jimmunol.167.11.6069] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
206 Stohl W, Merrill JT, Mckay JD, Lisse JR, Zhong ZJ, Freimuth WW, Genovese MC. Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study. J Rheumatol 2013;40:579-89. [DOI: 10.3899/jrheum.120886] [Cited by in Crossref: 61] [Cited by in F6Publishing: 52] [Article Influence: 7.6] [Reference Citation Analysis]
207 Zhu X, Shi Y, Peng J, Guo C, Shan N, Qin P, Ji X, Hou M. The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood 2009;114:5362-7. [DOI: 10.1182/blood-2009-05-217513] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
208 Montecino-Rodriguez E, Dorshkind K. Formation of B-1 B cells from neonatal B-1 transitional cells exhibits NF-κB redundancy. J Immunol 2011;187:5712-9. [PMID: 22031760 DOI: 10.4049/jimmunol.1102416] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
209 Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131:959-971. [PMID: 23465663 DOI: 10.1016/j.jaci.2013.01.046] [Cited by in Crossref: 214] [Cited by in F6Publishing: 171] [Article Influence: 26.8] [Reference Citation Analysis]
210 Arkatkar T, Jacobs HM, Du SW, Li QZ, Hudkins KL, Alpers CE, Rawlings DJ, Jackson SW. TACI deletion protects against progressive murine lupus nephritis induced by BAFF overexpression. Kidney Int 2018;94:728-40. [PMID: 29907458 DOI: 10.1016/j.kint.2018.03.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
211 Hardenberg G, Planelles L, Schwarte CM, van Bostelen L, Le Huong T, Hahne M, Medema JP. Specific TLR ligands regulate APRIL secretion by dendritic cells in a PKR-dependent manner. Eur J Immunol 2007;37:2900-11. [PMID: 17899538 DOI: 10.1002/eji.200737210] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
212 Parameswaran R, Yu M, Lyu MA, Lim M, Rosenblum MG, Groffen J, Heisterkamp N. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin. Leukemia 2012;26:1786-96. [PMID: 22373785 DOI: 10.1038/leu.2012.54] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
213 Asashima N, Fujimoto M, Watanabe R, Nakashima H, Yazawa N, Okochi H, Tamaki K. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris: Serum levels of BAFF are increased in BP but not in PV. British Journal of Dermatology 2006;155:330-6. [DOI: 10.1111/j.1365-2133.2006.07305.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
214 Smulski CR, Eibel H. BAFF and BAFF-Receptor in B Cell Selection and Survival. Front Immunol. 2018;9:2285. [PMID: 30349534 DOI: 10.3389/fimmu.2018.02285] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 23.3] [Reference Citation Analysis]
215 Rönnberg C, Lugaajju A, Nyman A, Hammar U, Bottai M, Lautenbach MJ, Sundling C, Kironde F, Persson KEM. A longitudinal study of plasma BAFF levels in mothers and their infants in Uganda, and correlations with subsets of B cells. PLoS One 2021;16:e0245431. [PMID: 33465125 DOI: 10.1371/journal.pone.0245431] [Reference Citation Analysis]
216 Wada K, Maeda K, Tajima K, Kato T, Kobata T, Yamakawa M. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas. Histopathology 2009;54:221-32. [DOI: 10.1111/j.1365-2559.2008.03203.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
217 Shen X, Zhang X, Xu G, Ju S. BAFF-R gene induced by IFN-γ in multiple myeloma cells is related to NF-κB signals. Cell Biochem Funct 2011;29:513-20. [PMID: 21744373 DOI: 10.1002/cbf.1780] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
218 Schweighoffer E, Vanes L, Nys J, Cantrell D, McCleary S, Smithers N, Tybulewicz VL. The BAFF receptor transduces survival signals by co-opting the B cell receptor signaling pathway. Immunity 2013;38:475-88. [PMID: 23453634 DOI: 10.1016/j.immuni.2012.11.015] [Cited by in Crossref: 135] [Cited by in F6Publishing: 120] [Article Influence: 16.9] [Reference Citation Analysis]
219 Szodoray P, Jonsson R. The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome. Scand J Immunol 2005;62:421-8. [PMID: 16305638 DOI: 10.1111/j.1365-3083.2005.01688.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 4.2] [Reference Citation Analysis]
220 Rathmell JC. B-cell homeostasis: digital survival or analog growth? Immunol Rev 2004;197:116-28. [DOI: 10.1111/j.0105-2896.2004.0096.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
221 Woodland RT, Fox CJ, Schmidt MR, Hammerman PS, Opferman JT, Korsmeyer SJ, Hilbert DM, Thompson CB. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111:750-60. [PMID: 17942753 DOI: 10.1182/blood-2007-03-077222] [Cited by in Crossref: 136] [Cited by in F6Publishing: 125] [Article Influence: 9.7] [Reference Citation Analysis]
222 Zhang H, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu H, Mountz JD. Depletion of Collagen II-Reactive T Cells and Blocking of B Cell Activation Prevents Collagen II-Induced Arthritis in DBA/1j Mice. J Immunol 2002;168:4164-72. [DOI: 10.4049/jimmunol.168.8.4164] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
223 Vugmeyster Y, Seshasayee D, Chang W, Storn A, Howell K, Sa S, Nelson T, Martin F, Grewal I, Gilkerson E. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys. Am J Pathol. 2006;168:476-489. [PMID: 16436662 DOI: 10.2353/ajpath.2006.050600] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
224 Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J Clin Med 2021;10:2235. [PMID: 34064035 DOI: 10.3390/jcm10112235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
225 Lee WI, Jaing TH, Hsieh MY, Kuo ML, Lin SJ, Huang JL. Distribution, infections, treatments and molecular analysis in a large cohort of patients with primary immunodeficiency diseases (PIDs) in Taiwan. J Clin Immunol 2006;26:274-83. [PMID: 16783466 DOI: 10.1007/s10875-006-9013-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
226 Yehudai D, Snir A, Peri R, Halasz K, Haj T, Odeh M, Kessel A. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand J Immunol 2012;76:371-7. [PMID: 22725135 DOI: 10.1111/j.1365-3083.2012.02752.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
227 Das S, Sutoh Y, Cancro MP, Rast JP, Han Q, Bommakanti G, Cooper MD, Hirano M. Ancient BCMA-like Genes Herald B Cell Regulation in Lampreys. J Immunol 2019;203:2909-16. [PMID: 31666307 DOI: 10.4049/jimmunol.1900026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
228 Jordan N, D'Cruz D. Current and emerging treatment options in the management of lupus. Immunotargets Ther. 2016;5:9-20. [PMID: 27529058 DOI: 10.2147/itt.s40675] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 4.6] [Reference Citation Analysis]
229 Ju ZL, Shi GY, Zuo JX, Zhang JW; Jian Sun. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice. Immunology 2007;120:281-9. [PMID: 17073941 DOI: 10.1111/j.1365-2567.2006.02500.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
230 Mongini PK, Inman JK, Han H, Fattah RJ, Abramson SB, Attur M. APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2. J Immunol 2006;176:6736-51. [PMID: 16709833 DOI: 10.4049/jimmunol.176.11.6736] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
231 Ding C. Belimumab, an anti-BLyS human monoclonal antibody for potential treatment of inflammatory autoimmune diseases. Expert Opinion on Biological Therapy 2008;8:1805-14. [DOI: 10.1517/14712598.8.11.1805] [Cited by in Crossref: 40] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
232 Shabgah AG, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohammadi M. The role of BAFF and APRIL in rheumatoid arthritis. J Cell Physiol 2019;234:17050-63. [PMID: 30941763 DOI: 10.1002/jcp.28445] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
233 Sindhava VJ, Scholz JL, Cancro MP. Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells. Front Immunol 2013;4:37. [PMID: 23443938 DOI: 10.3389/fimmu.2013.00037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
234 Treml LS, Carlesso G, Hoek KL, Stadanlick JE, Kambayashi T, Bram RJ, Cancro MP, Khan WN. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007;178:7531-9. [PMID: 17548587 DOI: 10.4049/jimmunol.178.12.7531] [Cited by in Crossref: 124] [Cited by in F6Publishing: 107] [Article Influence: 8.9] [Reference Citation Analysis]
235 Morrison MD, Reiley W, Zhang M, Sun SC. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway. J Biol Chem 2005;280:10018-24. [PMID: 15644327 DOI: 10.1074/jbc.M413634200] [Cited by in Crossref: 87] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
236 Jacob CO, Guo S, Jacob N, Pawar RD, Putterman C, Quinn WJ 3rd, Cancro MP, Migone TS, Stohl W. Dispensability of APRIL to the development of systemic lupus erythematosus in NZM 2328 mice. Arthritis Rheum 2012;64:1610-9. [PMID: 22127792 DOI: 10.1002/art.33458] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
237 Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases. Int Rev Immunol. 2017;36:3-19. [PMID: 28215100 DOI: 10.1080/08830185.2016.1276903] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 15.8] [Reference Citation Analysis]
238 Rolink AG, Andersson J, Melchers F. Molecular mechanisms guiding late stages of B-cell development. Immunol Rev 2004;197:41-50. [DOI: 10.1111/j.0105-2896.2004.0101.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
239 Commins SP, Borish L, Steinke JW. Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol 2010;125:S53-72. [PMID: 19932918 DOI: 10.1016/j.jaci.2009.07.008] [Cited by in Crossref: 254] [Cited by in F6Publishing: 197] [Article Influence: 21.2] [Reference Citation Analysis]
240 Moreaux J, Legouffe E, Jourdan E, Quittet P, Rème T, Lugagne C, Moine P, Rossi JF, Klein B, Tarte K. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004;103:3148-57. [PMID: 15070697 DOI: 10.1182/blood-2003-06-1984] [Cited by in Crossref: 362] [Cited by in F6Publishing: 312] [Article Influence: 20.1] [Reference Citation Analysis]
241 Berkowska MA, van der Burg M, van Dongen JJ, van Zelm MC. Checkpoints of B cell differentiation: visualizing Ig-centric processes. Ann N Y Acad Sci 2011;1246:11-25. [PMID: 22236426 DOI: 10.1111/j.1749-6632.2011.06278.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
242 Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B. A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis. Ann Neurol 2019;85:406-20. [PMID: 30635946 DOI: 10.1002/ana.25415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
243 Reddy SK, Hu T, Gudivada R, Staines KA, Wright KE, Vickerstaff L, Kothlow S, Hunt LG, Butter C, Kaspers B, Young JR. The BAFF-Interacting receptors of chickens. Developmental & Comparative Immunology 2008;32:1076-87. [DOI: 10.1016/j.dci.2008.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
244 Ma L, Li R, Huang H, Yuan J, Ou S, Xu T, Yu X, Liu X, Chen Y. Up-regulated BAFF and BAFF receptor expression in patients with intractable temporal lobe epilepsy and a pilocarpine-induced epilepsy rat model. Seizure 2017;48:79-88. [DOI: 10.1016/j.seizure.2017.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
245 Sun J, Li Y, Yu M, Sun Y, Feng J, Shen B. Analysis of an anti-B lymphocyte stimulator monoclonal antibody B7 and its binding activity to myeloma and lymphoma cell lines. Hybridoma (Larchmt) 2006;25:238-42. [PMID: 16934021 DOI: 10.1089/hyb.2006.25.238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
246 Thibault-Espitia A, Foucher Y, Danger R, Migone T, Pallier A, Castagnet S, G-Gueguen C, Devys A, C-Gautier A, Giral M. BAFF and BAFF-R levels are associated with risk of long-term kidney graft dysfunction and development of donor-specific antibodies. Am J Transplant. 2012;12:2754-2762. [PMID: 22883025 DOI: 10.1111/j.1600-6143.2012.04194.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.1] [Reference Citation Analysis]
247 Königsberger S, Kiefer F. The BAFFling function of Syk in B-cell homeostasis. EMBO J 2015;34:838-40. [PMID: 25712210 DOI: 10.15252/embj.201591120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
248 Hatzoglou A, Deshayes F, Madry C, Laprée G, Castanas E, Tsapis A. Natural antisense RNA inhibits the expression of BCMA, a tumour necrosis factor receptor homologue. BMC Mol Biol 2002;3:4. [PMID: 11960555 DOI: 10.1186/1471-2199-3-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
249 Ouchida R, Lu Q, Liu J, Li Y, Chu Y, Tsubata T, Wang JY. FcμR interacts and cooperates with the B cell receptor To promote B cell survival. J Immunol 2015;194:3096-101. [PMID: 25732732 DOI: 10.4049/jimmunol.1402352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
250 Ryan MC, Grewal IS. Targeting of BAFF and APRIL for Autoimmunity and Oncology. In: Grewal IS, editor. Therapeutic Targets of the TNF Superfamily. New York: Springer; 2009. pp. 52-63. [DOI: 10.1007/978-0-387-89520-8_4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
251 Hu H, Wu X, Jin W, Chang M, Cheng X, Sun SC. Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development. Proc Natl Acad Sci U S A 2011;108:12827-32. [PMID: 21768353 DOI: 10.1073/pnas.1105774108] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 5.4] [Reference Citation Analysis]
252 Chang Y, Wu Y, Wang D, Wei W, Qin Q, Xie G, Zhang L, Yan S, Chen J, Wang Q, Wu H, Xiao F, Sun W, Jin J, Wang W. Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology 2011;50:862-70. [DOI: 10.1093/rheumatology/keq404] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
253 Zouali M. B cell diversity and longevity in systemic autoimmunity. Molecular Immunology 2002;38:895-901. [DOI: 10.1016/s0161-5890(02)00016-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
254 Gupta M, Dillon SR, Ziesmer SC, Feldman AL, Witzig TE, Ansell SM, Cerhan JR, Novak AJ. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood 2009;113:5206-16. [PMID: 19321861 DOI: 10.1182/blood-2008-09-179762] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
255 Yang CH, Murti A, Pfeffer LM. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival. J Biol Chem 2005;280:31530-6. [PMID: 16009713 DOI: 10.1074/jbc.M503120200] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
256 Baker KP. BLyS—an essential survival factor for B cells: basic biology, links to pathology and therapeutic target. Autoimmunity Reviews 2004;3:368-75. [DOI: 10.1016/j.autrev.2004.02.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
257 Salzer U, Grimbacher B. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity?: New genetic defects in common variable immunodeficiency. Current Opinion in Allergy & Clinical Immunology 2005;5:496-503. [DOI: 10.1097/01.all.0000191887.89773.cc] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
258 Elsawa SF, Novak AJ, Grote DM, Ziesmer SC, Witzig TE, Kyle RA, Dillon SR, Harder B, Gross JA, Ansell SM. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Blood 2006;107:2882-8. [PMID: 16304043 DOI: 10.1182/blood-2005-09-3552] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 4.3] [Reference Citation Analysis]
259 Suekane S, Ueda K, Nishihara K, Sasada T, Yamashita T, Koga N, Yutani S, Shichijo S, Itoh K, Igawa T, Noguchi M. Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma. Cancer Sci 2017;108:2430-7. [PMID: 28940789 DOI: 10.1111/cas.13404] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
260 Ni C, Oganesyan G, Welsh K, Zhu X, Reed JC, Satterthwait AC, Cheng G, Ely KR. Key Molecular Contacts Promote Recognition of the BAFF Receptor by TNF Receptor-Associated Factor 3: Implications for Intracellular Signaling Regulation. J Immunol 2004;173:7394-400. [DOI: 10.4049/jimmunol.173.12.7394] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
261 Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3:822-829. [PMID: 12154359 DOI: 10.1038/ni829] [Cited by in Crossref: 909] [Cited by in F6Publishing: 838] [Article Influence: 47.8] [Reference Citation Analysis]
262 Mayne CG, Amanna IJ, Hayes CE. Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival. Mol Immunol 2009;47:590-9. [PMID: 19815275 DOI: 10.1016/j.molimm.2009.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
263 Alexaki V, Pelekanou V, Notas G, Venihaki M, Kampa M, Dessirier V, Sabour-alaoui S, Stathopoulos EN, Tsapis A, Castanas E. B-Cell Maturation Antigen (BCMA) Activation Exerts Specific Proinflammatory Effects in Normal Human Keratinocytes and Is Preferentially Expressed in Inflammatory Skin Pathologies. Endocrinology 2012;153:739-49. [DOI: 10.1210/en.2011-1504] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
264 Kalled SL. Impact of the BAFF/BR3 axis on B cell survival, germinal center maintenance and antibody production. Semin Immunol 2006;18:290-6. [PMID: 16931038 DOI: 10.1016/j.smim.2006.06.002] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.8] [Reference Citation Analysis]
265 Hikida M, Johmura S, Hashimoto A, Takezaki M, Kurosaki T. Coupling between B cell receptor and phospholipase C-gamma2 is essential for mature B cell development. J Exp Med 2003;198:581-9. [PMID: 12913095 DOI: 10.1084/jem.20030280] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
266 Cancro MP, D'Cruz DP, Khamashta MA. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest 2009;119:1066-73. [PMID: 19411764 DOI: 10.1172/JCI38010] [Cited by in Crossref: 177] [Cited by in F6Publishing: 68] [Article Influence: 14.8] [Reference Citation Analysis]
267 Robeva AS, Yan-Neale Y, Burfeind P, Bodian DL, Chirn GW, Kolbinger F, Labow M, Vallon RD. Rapid expression cloning of receptors using epitope-tagged ligands and high-speed cell sorting. Cytometry A 2003;51:59-67. [PMID: 12541280 DOI: 10.1002/cyto.a.10012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
268 George-Chandy A, Trysberg E, Eriksson K. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms. Arthritis Res Ther 2008;10:R97. [PMID: 18718031 DOI: 10.1186/ar2484] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
269 Pott MC, Frede N, Wanders J, Hammarström L, Glocker EO, Glocker C, Tahami F, Grimbacher B. Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies? BMC Immunol 2017;18:34. [PMID: 28651547 DOI: 10.1186/s12865-017-0217-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
270 Amanna IJ, Dingwall JP, Hayes CE. Enforced bcl-xL Gene Expression Restored Splenic B Lymphocyte Development in BAFF-R Mutant Mice. J Immunol 2003;170:4593-600. [DOI: 10.4049/jimmunol.170.9.4593] [Cited by in Crossref: 79] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
271 Fu L, Lin-Lee YC, Pham LV, Tamayo A, Yoshimura L, Ford RJ. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 2006;107:4540-8. [PMID: 16497967 DOI: 10.1182/blood-2005-10-4042] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 8.3] [Reference Citation Analysis]
272 Li K, McGee LR, Fisher B, Sudom A, Liu J, Rubenstein SM, Anwer MK, Cushing TD, Shin Y, Ayres M, Lee F, Eksterowicz J, Faulder P, Waszkowycz B, Plotnikova O, Farrelly E, Xiao SH, Chen G, Wang Z. Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures. Bioorg Med Chem Lett 2013;23:1238-44. [PMID: 23374866 DOI: 10.1016/j.bmcl.2013.01.012] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
273 Tusche MW, Ward LA, Vu F, McCarthy D, Quintela-Fandino M, Ruland J, Gommerman JL, Mak TW. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med 2009;206:2671-83. [PMID: 19917778 DOI: 10.1084/jem.20091802] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
274 Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 2007;66:790-7. [PMID: 17185325 DOI: 10.1136/ard.2006.065656] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
275 Cao P, Zhang S, Zhang J, Wang M. Construction and characterization of a bi-functional EGFP/sBAFF fusion protein. Biochimie 2006;88:629-35. [DOI: 10.1016/j.biochi.2005.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
276 Dörner T, Lipsky PE. Signalling pathways in B cells: implications for autoimmunity. Curr Top Microbiol Immunol 2006;305:213-40. [PMID: 16724808 DOI: 10.1007/3-540-29714-6_11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 0.5] [Reference Citation Analysis]
277 Chang SK, Mihalcik SA, Jelinek DF. B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation. J Immunol 2008;180:7394-403. [PMID: 18490739 DOI: 10.4049/jimmunol.180.11.7394] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
278 Stein JV, López-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodríguez D, Gómez-Caro R, De Jong J, Martínez-A C, Medema JP, Hahne M. APRIL modulates B and T cell immunity. J Clin Invest. 2002;109:1587-1598. [PMID: 12070306 DOI: 10.1172/jci200215034] [Cited by in Crossref: 23] [Article Influence: 1.2] [Reference Citation Analysis]
279 Yu M, Chen Y, He Y, Podd A, Fu G, Wright JA, Kleiman E, Khan WN, Wen R, Wang D. Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells. J Immunol 2012;189:5185-93. [PMID: 23087406 DOI: 10.4049/jimmunol.1102952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
280 Yiwen Z, Shilin G, Yingshi C, Lishi S, Baohong L, Chao L, Linghua L, Ting P, Hui Z. Efficient generation of antigen-specific CTLs by the BAFF-activated human B Lymphocytes as APCs: a novel approach for immunotherapy. Oncotarget 2016;7:77732-48. [PMID: 27780916 DOI: 10.18632/oncotarget.12792] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
281 Zhou T, Mountz JD, Kimberly RP. Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 2002;26:323-36. [PMID: 12403370 DOI: 10.1385/IR:26:1-3:323] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
282 Garić D, Tao S, Ahmed E, Youssef M, Kanagaratham C, Shah J, Mazer B, Radzioch D. Depletion of BAFF cytokine exacerbates infection in Pseudomonas aeruginosa infected mice. Journal of Cystic Fibrosis 2019;18:349-56. [DOI: 10.1016/j.jcf.2018.11.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
283 Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST. CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells. Diabetes 2009;58:1568-77. [PMID: 19336675 DOI: 10.2337/db08-1504] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
284 Lang J, Zhang B, Kelly M, Peterson JN, Barbee J, Freed BM, Di Santo JP, Matsuda JL, Torres RM, Pelanda R. Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice. Blood Adv 2017;1:2729-41. [PMID: 29296925 DOI: 10.1182/bloodadvances.2017010090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
285 Isenberg DA. Treating patients with lupus with B-cell depletion. Lupus 2008;17:400-4. [PMID: 18490416 DOI: 10.1177/0961203308090024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
286 Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum 2007;56:1134-44. [PMID: 17393395 DOI: 10.1002/art.22458] [Cited by in Crossref: 153] [Cited by in F6Publishing: 127] [Article Influence: 10.9] [Reference Citation Analysis]
287 Mues G, Tardivel A, Willen L, Kapadia H, Seaman R, Frazier-Bowers S, Schneider P, D'Souza RN. Functional analysis of Ectodysplasin-A mutations causing selective tooth agenesis. Eur J Hum Genet 2010;18:19-25. [PMID: 19623212 DOI: 10.1038/ejhg.2009.127] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
288 Pound J. A key role for BAFF in maintaining peripheral B cells. Trends in Immunology 2001;22:659. [DOI: 10.1016/s1471-4906(01)02122-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
289 Zhu X, Shi Y, Zhang F, Yao Q, Liu Y, Shan N, Wang D, Peng J, Xu J, Hou M. Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia. Br J Haematol 2014;166:783-91. [DOI: 10.1111/bjh.12958] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
290 Nicoletti AM, Kenny CH, Khalil AM, Pan Q, Ralph KLM, Ritchie J, Venkataramani S, Presky DH, Dewire SM, Brodeur SR. Unexpected Potency Differences between B-Cell-Activating Factor (BAFF) Antagonist Antibodies against Various Forms of BAFF: Trimer, 60-Mer, and Membrane-Bound. Journal of Pharmacology and Experimental Therapeutics 2016;359:37-44. [DOI: 10.1124/jpet.116.236075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
291 Durandy A, Revy P, Imai K, Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 2005;203:67-79. [DOI: 10.1111/j.0105-2896.2005.00222.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 3.9] [Reference Citation Analysis]
292 Kohno T, Daa T, Otani H, Shimokawa I, Yokoyama S, Matsuyama T. Aberrant expression of BAFF receptor, a member of the tumor necrosis factor receptor family, in malignant cells of nonhematopoietic origins. Genes to Cells 2008;13:1061-73. [DOI: 10.1111/j.1365-2443.2008.01227.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
293 Otipoby KL, Sasaki Y, Schmidt-Supprian M, Patke A, Gareus R, Pasparakis M, Tarakhovsky A, Rajewsky K. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci U S A 2008;105:12435-8. [PMID: 18713867 DOI: 10.1073/pnas.0805460105] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
294 Medema JP, Planelles-carazo L, Hardenberg G, Hahne M. The uncertain glory of APRIL. Cell Death Differ 2003;10:1121-5. [DOI: 10.1038/sj.cdd.4401291] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
295 Defrance T, Casamayor-Pallejà M, Krammer PH. The life and death of a B cell. Adv Cancer Res 2002;86:195-225. [PMID: 12374279 DOI: 10.1016/s0065-230x(02)86006-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
296 Lee SJ, Long M, Adler AJ, Mittler RS, Vella AT. The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death. J Leukoc Biol 2009;85:175-85. [PMID: 18923104 DOI: 10.1189/jlb.0408248] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
297 Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004;103:679-88. [PMID: 14504101 DOI: 10.1182/blood-2003-02-0540] [Cited by in Crossref: 223] [Cited by in F6Publishing: 194] [Article Influence: 12.4] [Reference Citation Analysis]
298 Jacob CO, Pricop L, Putterman C, Koss MN, Liu Y, Kollaros M, Bixler SA, Ambrose CM, Scott ML, Stohl W. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol 2006;177:2671-80. [PMID: 16888029 DOI: 10.4049/jimmunol.177.4.2671] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 5.3] [Reference Citation Analysis]
299 Rawlings DJ, Metzler G, Wray-Dutra M, Jackson SW. Altered B cell signalling in autoimmunity. Nat Rev Immunol 2017;17:421-36. [PMID: 28393923 DOI: 10.1038/nri.2017.24] [Cited by in Crossref: 112] [Cited by in F6Publishing: 97] [Article Influence: 28.0] [Reference Citation Analysis]
300 du Plessis WJ, Walzl G, Loxton AG. B cells as multi-functional players during Mycobacterium tuberculosis infection and disease. Tuberculosis (Edinb) 2016;97:118-25. [PMID: 26611659 DOI: 10.1016/j.tube.2015.10.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
301 Maurer MA, Tuller F, Gredler V, Berger T, Lutterotti A, Lünemann JD, Reindl M. Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination. Journal of Neuroimmunology 2016;290:49-53. [DOI: 10.1016/j.jneuroim.2015.11.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
302 Lyu MA, Pham LV, Sung B, Tamayo AT, Ahn KS, Hittelman WN, Cheung LH, Marks JW, Cho MJ, Ford RJ, Aggarwal BB, Rosenblum MG. The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma. Biochem Pharmacol 2012;84:451-8. [PMID: 22687624 DOI: 10.1016/j.bcp.2012.05.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
303 Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Roschke V, Wu Y, Baker KP, Hilbert DM. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004;63:1096-103. [PMID: 15308519 DOI: 10.1136/ard.2003.018663] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 4.2] [Reference Citation Analysis]
304 Sun J, Lin Z, Feng J, Li Y, Shen B. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases. European Journal of Pharmacology 2008;597:1-5. [DOI: 10.1016/j.ejphar.2008.08.027] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
305 Salazar-camarena DC, Ortiz-lazareno PC, Cruz A, Oregon-romero E, Machado-contreras JR, Muñoz-valle JF, Orozco-lópez M, Marín-rosales M, Palafox-sánchez CA. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus. Lupus 2016;25:582-92. [DOI: 10.1177/0961203315608254] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 9.8] [Reference Citation Analysis]
306 Gorelik L, Cutler AH, Thill G, Miklasz SD, Shea DE, Ambrose C, Bixler SA, Su L, Scott ML, Kalled SL. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 2004;172:762-6. [PMID: 14707045 DOI: 10.4049/jimmunol.172.2.762] [Cited by in Crossref: 126] [Cited by in F6Publishing: 116] [Article Influence: 7.4] [Reference Citation Analysis]
307 Chang Y, Jia X, Sun X, Xu S, Wu Y, Zhang L, Wei W. APRIL promotes proliferation, secretion and invasion of fibroblast-like synoviocyte from rats with adjuvant induced arthritis. Molecular Immunology 2015;64:90-8. [DOI: 10.1016/j.molimm.2014.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
308 Gardam S, Brink R. Non-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple Junctures. Front Immunol 2014;4:509. [PMID: 24432023 DOI: 10.3389/fimmu.2013.00509] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
309 Shen Y, Wang S, Ai H, Min C, Chen Y, Zhang S. Molecular structure, bioinformatics analysis, expression and bioactivity of BAFF (TNF13B) in dog (Canis familiaris). Veterinary Immunology and Immunopathology 2011;142:133-9. [DOI: 10.1016/j.vetimm.2011.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
310 Stohl W. Editorial: The BAFFling Immunology of Systemic Lupus Erythematosus: Beyond B Cells: Editorial. Arthritis & Rheumatology 2015;67:612-5. [DOI: 10.1002/art.38951] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
311 Stohl HE, Yu N, Stohl W. First-trimester serum BAFF:sFlt-1 ratio as a candidate early biomarker of spontaneous abortion. Am J Reprod Immunol 2021;:e13428. [PMID: 33837577 DOI: 10.1111/aji.13428] [Reference Citation Analysis]
312 Kaur K, Chowdhury S, Greenspan NS, Schreiber JR. Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates. Blood 2007;110:2948-54. [PMID: 17634409 DOI: 10.1182/blood-2007-01-069245] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
313 Weinstein JA, Zeng X, Chien YH, Quake SR. Correlation of gene expression and genome mutation in single B-cells. PLoS One 2013;8:e67624. [PMID: 23840752 DOI: 10.1371/journal.pone.0067624] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
314 Martin P, Duran A, Minguet S, Gaspar ML, Diaz-Meco MT, Rennert P, Leitges M, Moscat J. Role of zeta PKC in B-cell signaling and function. EMBO J 2002;21:4049-57. [PMID: 12145205 DOI: 10.1093/emboj/cdf407] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 5.2] [Reference Citation Analysis]
315 Zheng Y, Gallucci S, Gaughan JP, Gross JA, Monestier M. A role for B cell-activating factor of the TNF family in chemically induced autoimmunity. J Immunol 2005;175:6163-8. [PMID: 16237113 DOI: 10.4049/jimmunol.175.9.6163] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
316 Kanswal S, Katsenelson N, Allman W, Uslu K, Blake MS, Akkoyunlu M. Suppressive effect of bacterial polysaccharides on BAFF system is responsible for their poor immunogenicity. J Immunol 2011;186:2430-43. [PMID: 21248261 DOI: 10.4049/jimmunol.1002976] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
317 Yeramilli VA, Knight KL. Somatically diversified and proliferating transitional B cells: implications for peripheral B cell homeostasis. J Immunol 2011;186:6437-44. [PMID: 21525392 DOI: 10.4049/jimmunol.1003897] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
318 Ge XJ, Wang YL, Wu YP, Feng ZX, Liu L, Li MY, Jiang JY. Regulatory effect of Act1 on the BAFF pathway in B-cell malignancy. Oncol Lett 2019;17:3727-34. [PMID: 30930983 DOI: 10.3892/ol.2019.10047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
319 Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T, Fairfull L, Ferrell RE, Foon KA, Hunt DF, Shabanowitz J, Engelhard VH, Riddell SR, Warren EH. The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL. Blood 2006;107:3779-86. [PMID: 16391015 DOI: 10.1182/blood-2005-08-3501] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 5.3] [Reference Citation Analysis]
320 Kramer NJ, Wang WL, Reyes EY, Kumar B, Chen CC, Ramakrishna C, Cantin EM, Vonderfecht SL, Taganov KD, Chau N, Boldin MP. Altered lymphopoiesis and immunodeficiency in miR-142 null mice. Blood 2015;125:3720-30. [PMID: 25931583 DOI: 10.1182/blood-2014-10-603951] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 10.7] [Reference Citation Analysis]
321 Guan Z, Ye J, Dan W, Yao W, Zhang S. Cloning, expression and bioactivity of duck BAFF. Molecular Immunology 2007;44:1471-6. [DOI: 10.1016/j.molimm.2006.05.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
322 Ashkenazi A. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer. 2002;2:420-430. [PMID: 12189384 DOI: 10.1038/nrc821] [Cited by in Crossref: 910] [Cited by in F6Publishing: 754] [Article Influence: 47.9] [Reference Citation Analysis]
323 Kanno Y, Sakurai D, Hase H, Kojima H, Kobata T. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-κB signaling. Journal of Receptors and Signal Transduction 2010;30:121-32. [DOI: 10.3109/10799891003634509] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
324 McWilliams EM, Lucas CR, Chen T, Harrington BK, Wasmuth R, Campbell A, Rogers KA, Cheney CM, Mo X, Andritsos LA, Awan FT, Woyach J, Carson WE 3rd, Butchar J, Tridandapani S, Hertlein E, Castro CE, Muthusamy N, Byrd JC. Anti-BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib. Blood Adv 2019;3:447-60. [PMID: 30737226 DOI: 10.1182/bloodadvances.2018025684] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
325 Ansell SM, Novak AJ, Ziesmer S, Price-Troska T, LaPlant B, Dillon SR, Witzig TE. Serum BLyS levels increase after rituximab as initial therapy in patients with follicular Grade 1 non-Hodgkin lymphoma. Am J Hematol 2009;84:71-3. [PMID: 19051265 DOI: 10.1002/ajh.21328] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
326 Ganeff C, Remouchamps C, Boutaffala L, Benezech C, Galopin G, Vandepaer S, Bouillenne F, Ormenese S, Chariot A, Schneider P, Caamaño J, Piette J, Dejardin E. Induction of the alternative NF-κB pathway by lymphotoxin αβ (LTαβ) relies on internalization of LTβ receptor. Mol Cell Biol 2011;31:4319-34. [PMID: 21896778 DOI: 10.1128/MCB.05033-11] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
327 Sakurai D, Kanno Y, Hase H, Kojima H, Okumura K, Kobata T. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur J Immunol 2007;37:110-8. [PMID: 17154264 DOI: 10.1002/eji.200636623] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
328 McClements M, Williams S, Ball C, Bristow A, Wadhwa M, Meager A. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells. J Immunol Methods 2008;337:63-70. [PMID: 18625509 DOI: 10.1016/j.jim.2008.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
329 Sutherland AP, Ng LG, Fletcher CA, Shum B, Newton RA, Grey ST, Rolph MS, Mackay F, Mackay CR. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005;174:5537-44. [PMID: 15843552 DOI: 10.4049/jimmunol.174.9.5537] [Cited by in Crossref: 111] [Cited by in F6Publishing: 102] [Article Influence: 6.9] [Reference Citation Analysis]
330 Miyazawa M, Tsuji-Kawahara S, Kanari Y. Host genetic factors that control immune responses to retrovirus infections. Vaccine 2008;26:2981-96. [PMID: 18255203 DOI: 10.1016/j.vaccine.2008.01.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
331 Rahman ZS, Manser T. B cells expressing Bcl-2 and a signaling-impaired BAFF-specific receptor fail to mature and are deficient in the formation of lymphoid follicles and germinal centers. J Immunol 2004;173:6179-88. [PMID: 15528355 DOI: 10.4049/jimmunol.173.10.6179] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
332 Matsushita T, Fujimoto M, Echigo T, Matsushita Y, Shimada Y, Hasegawa M, Takehara K, Sato S. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis. Experimental Dermatology 2008;17:197-202. [DOI: 10.1111/j.1600-0625.2007.00642.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
333 Brink R. Regulation of B cell self-tolerance by BAFF. Semin Immunol 2006;18:276-83. [PMID: 16916609 DOI: 10.1016/j.smim.2006.04.003] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 3.9] [Reference Citation Analysis]
334 Foster D, Parrish-novak J, Fox B, Xu W. Cytokine–receptor pairing: accelerating discovery of cytokine function. Nat Rev Drug Discov 2004;3:160-70. [DOI: 10.1038/nrd1305] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
335 Pena-Rossi C, Nasonov E, Stanislav M, Yakusevich V, Ershova O, Lomareva N, Saunders H, Hill J, Nestorov I. An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus. Lupus. 2009;18:547-555. [PMID: 19395457 DOI: 10.1177/0961203309102803] [Cited by in Crossref: 88] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
336 Möckel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE). Autoimmun Rev 2021;20:102736. [PMID: 33333233 DOI: 10.1016/j.autrev.2020.102736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
337 Fehres CM, van Uden NO, Yeremenko NG, Fernandez L, Franco Salinas G, van Duivenvoorde LM, Huard B, Morel J, Spits H, Hahne M, Baeten DLP. APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1. Front Immunol 2019;10:1368. [PMID: 31258536 DOI: 10.3389/fimmu.2019.01368] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
338 Lin WW, Hildebrand JM, Bishop GA. A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes. Front Immunol 2013;4:477. [PMID: 24391649 DOI: 10.3389/fimmu.2013.00477] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
339 Ramanujam M, Wang X, Huang W, Schiffer L, Grimaldi C, Akkerman A, Diamond B, Madaio MP, Davidson A. Mechanism of Action of Transmembrane Activator and Calcium Modulator Ligand Interactor-Ig in Murine Systemic Lupus Erythematosus. J Immunol 2004;173:3524-34. [DOI: 10.4049/jimmunol.173.5.3524] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 5.7] [Reference Citation Analysis]
340 Ren W, Pang S, You F, Zhou L, Zhang S. The first BAFF gene cloned from the cartilaginous fish. Fish Shellfish Immunol 2011;31:1088-96. [PMID: 21959037 DOI: 10.1016/j.fsi.2011.09.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
341 Liu Y, Liu H, Peng Y, Liu F. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production? Renal Failure 2014;36:970-3. [DOI: 10.3109/0886022x.2014.916578] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
342 Wen X, Lyu MA, Zhang R, Lu W, Huang Q, Liang D, Rosenblum MG, Li C. Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma. Mol Imaging Biol 2011;13:721-9. [PMID: 20686856 DOI: 10.1007/s11307-010-0391-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
343 Karpusas M, Cachero TG, Qian F, Boriack-sjodin A, Mullen C, Strauch K, Hsu Y, Kalled SL. Crystal structure of extracellular human BAFF, a TNF family member that stimulates B lymphocytes. Journal of Molecular Biology 2002;315:1145-54. [DOI: 10.1006/jmbi.2001.5296] [Cited by in Crossref: 102] [Cited by in F6Publishing: 84] [Article Influence: 5.4] [Reference Citation Analysis]
344 Xiao G, Fong A, Sun SC. Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. J Biol Chem 2004;279:30099-105. [PMID: 15140882 DOI: 10.1074/jbc.M401428200] [Cited by in Crossref: 187] [Cited by in F6Publishing: 115] [Article Influence: 11.0] [Reference Citation Analysis]
345 Parodis I, Axelsson M, Gunnarsson I. Belimumab for systemic lupus erythematosus: a practice-based view. Lupus 2013;22:372-80. [PMID: 23553780 DOI: 10.1177/0961203313476154] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
346 Saito Y, Miyagawa Y, Onda K, Nakajima H, Sato B, Horiuchi Y, Okita H, Katagiri YU, Saito M, Shimizu T, Fujimoto J, Kiyokawa N. B-cell-activating factor inhibits CD20-mediated and B-cell receptor-mediated apoptosis in human B cells. Immunology 2008;125:570-90. [PMID: 18540961 DOI: 10.1111/j.1365-2567.2008.02872.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
347 Melchers F. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann Rheum Dis 2003;62 Suppl 2:ii25-7. [PMID: 14532143 DOI: 10.1136/ard.62.suppl_2.ii25] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
348 Yoshimoto K, Suzuki K, Takei E, Ikeda Y, Takeuchi T. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome. Arthritis Res Ther 2020;22:157. [PMID: 32576236 DOI: 10.1186/s13075-020-02249-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Jing S, Lu J, Song J, Luo S, Zhou L, Quan C, Xi J, Zhao C. Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis. Journal of Neuroimmunology 2019;332:216-23. [DOI: 10.1016/j.jneuroim.2019.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
350 Lyu M, Cheung LH, Hittelman WN, Liu Y, Marks JW, Cho M, Rosenblum MG. Bax345/BLyS: A novel, completely human fusion protein targeting malignant B cells and delivering a unique mitochondrial toxin. Cancer Letters 2012;322:159-68. [DOI: 10.1016/j.canlet.2012.02.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
351 Liu Y, Yuan X, Li L, Lin L, Zuo X, Cong Y, Li Y. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol 2020;11:e00146. [PMID: 32352710 DOI: 10.14309/ctg.0000000000000146] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
352 Soleto I, Morel E, Martín D, Granja AG, Tafalla C. Regulation of IgM+ B Cell Activities by Rainbow Trout APRIL Reveals Specific Effects of This Cytokine in Lower Vertebrates. Front Immunol 2018;9:1880. [PMID: 30150995 DOI: 10.3389/fimmu.2018.01880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
353 Naoufal R, Legendre M, Couet D, Gilbert-Dussardier B, Kitzis A, Bilan F, Harbuz R. Association of structural and numerical anomalies of chromosome 22 in a patient with syndromic intellectual disability. Eur J Med Genet 2016;59:483-7. [PMID: 27452446 DOI: 10.1016/j.ejmg.2016.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
354 Thangarajh M, Masterman T, Helgeland L, Rot U, Jonsson MV, Eide GE, Pirskanen R, Hillert J, Jonsson R. The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis. J Neuroimmunol 2006;178:161-6. [PMID: 16820216 DOI: 10.1016/j.jneuroim.2006.05.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
355 Nozari A, Berezovski MV. Aptamers for CD Antigens: From Cell Profiling to Activity Modulation. Mol Ther Nucleic Acids 2017;6:29-44. [PMID: 28325295 DOI: 10.1016/j.omtn.2016.12.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
356 Cope AP, Feldmann M. Emerging approaches for the therapy of autoimmune and chronic inflammatory disease. Current Opinion in Immunology 2004;16:780-6. [DOI: 10.1016/j.coi.2004.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
357 Warnatz K, Salzer U, Rizzi M, Fischer B, Gutenberger S, Böhm J, Kienzler AK, Pan-Hammarström Q, Hammarström L, Rakhmanov M, Schlesier M, Grimbacher B, Peter HH, Eibel H. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A 2009;106:13945-50. [PMID: 19666484 DOI: 10.1073/pnas.0903543106] [Cited by in Crossref: 250] [Cited by in F6Publishing: 214] [Article Influence: 20.8] [Reference Citation Analysis]
358 Liu H, Zhang J, Li J, Song J, Zhang S. Molecular structure, distribution, and immunology function of TNFSF13B (BAFF) in Nile tilapia (Oreochromis niloticus). Fish & Shellfish Immunology 2016;51:240-50. [DOI: 10.1016/j.fsi.2016.02.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
359 Warnatz K, Schlesier M. Flowcytometric phenotyping of common variable immunodeficiency. Cytometry B Clin Cytom 2008;74:261-71. [PMID: 18561200 DOI: 10.1002/cyto.b.20432] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 7.3] [Reference Citation Analysis]
360 Koarada S, Tada Y, Sohma Y, Haruta Y, Suematsu R, Mitamura M, Inoue H, Ehara H, Tokoro Y, Ohta A. Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects. Rheumatology (Oxford). 2010;49:662-670. [PMID: 20097906 DOI: 10.1093/rheumatology/kep437] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
361 Li X, Xiao B, Xi J, Lu C, Lu J. Decrease of CD4+CD25highFoxp3+ regulatory T cells and elevation of CD19+BAFF-R+ B cells and soluble ICAM-1 in myasthenia gravis. Clinical Immunology 2008;126:180-8. [DOI: 10.1016/j.clim.2007.10.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
362 Edwards BM, Barash SC, Main SH, Choi GH, Minter R, Ullrich S, Williams E, Du Fou L, Wilton J, Albert VR, Ruben SM, Vaughan TJ. The Remarkable Flexibility of the Human Antibody Repertoire; Isolation of Over One Thousand Different Antibodies to a Single Protein, BLyS. Journal of Molecular Biology 2003;334:103-18. [DOI: 10.1016/j.jmb.2003.09.054] [Cited by in Crossref: 80] [Cited by in F6Publishing: 64] [Article Influence: 4.4] [Reference Citation Analysis]
363 Cui XW, Li JF, Xiao W, Xuan Y, Tian AY, Xu XZ, Zhang SQ. Molecular cloning, expression and functional analysis of TNF13b (BAFF) in Japanese sea perch, Lateolabrax japonicus. Int Immunopharmacol 2012;12:34-41. [PMID: 22032840 DOI: 10.1016/j.intimp.2011.10.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
364 Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, Fairchild RL, Omori SA, Rickert RC, Scott M, Kotzin BL, Li X. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 2004;21:575-87. [PMID: 15485634 DOI: 10.1016/j.immuni.2004.09.001] [Cited by in Crossref: 117] [Cited by in F6Publishing: 105] [Article Influence: 6.9] [Reference Citation Analysis]
365 Liu Y, Hong X, Kappler J, Jiang L, Zhang R, Xu L, Pan C, Martin WE, Murphy RC, Shu H, Dai S, Zhang G. Ligand–receptor binding revealed by the TNF family member TALL-1. Nature 2003;423:49-56. [DOI: 10.1038/nature01543] [Cited by in Crossref: 96] [Cited by in F6Publishing: 80] [Article Influence: 5.3] [Reference Citation Analysis]
366 Jackson SW, Scharping NE, Jacobs HM, Wang S, Chait A, Rawlings DJ. Cutting Edge: BAFF Overexpression Reduces Atherosclerosis via TACI-Dependent B Cell Activation. J Immunol 2016;197:4529-34. [PMID: 27837104 DOI: 10.4049/jimmunol.1601198] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
367 Nestorov I, Munafo A, Papasouliotis O, Visich J. Pharmacokinetics and biological activity of atacicept in patients with rheumatoid arthritis. J Clin Pharmacol 2008;48:406-17. [PMID: 18303125 DOI: 10.1177/0091270008315312] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
368 Yazdani R, Hakemi MG, Sherkat R, Homayouni V, Farahani R. Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Adv Biomed Res 2014;3:2. [PMID: 24600593 DOI: 10.4103/2277-9175.124627] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
369 Lyu MA, Rai D, Ahn KS, Sung B, Cheung LH, Marks JW, Aggarwal BB, Aguiar RC, Gandhi V, Rosenblum MG. The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. Neoplasia 2010;12:366-75. [PMID: 20454508 DOI: 10.1593/neo.91960] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
370 Xu X, Huang S, Xiao X, Sun Q, Liang X, Chen S, Zhao Z, Huo Z, Tu S, Li Y. Challenges and Clinical Strategies of CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Overview and Developments. Front Immunol 2020;11:569117. [PMID: 33643279 DOI: 10.3389/fimmu.2020.569117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
371 Ohashi PS, Defranco AL. Making and breaking tolerance. Current Opinion in Immunology 2002;14:744-59. [DOI: 10.1016/s0952-7915(02)00406-5] [Cited by in Crossref: 73] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
372 Stepensky P, Keller B, Buchta M, Kienzler AK, Elpeleg O, Somech R, Cohen S, Shachar I, Miosge LA, Schlesier M, Fuchs I, Enders A, Eibel H, Grimbacher B, Warnatz K. Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects. J Allergy Clin Immunol 2013;131:477-85.e1. [PMID: 23374270 DOI: 10.1016/j.jaci.2012.11.050] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 16.0] [Reference Citation Analysis]
373 Kessel A, Yehudai D, Peri R, Pavlotzky E, Bamberger E, Tov N, Toubi E. Increased susceptibility of cord blood B lymphocytes to undergo spontaneous apoptosis. Clin Exp Immunol 2006;145:563-70. [PMID: 16907927 DOI: 10.1111/j.1365-2249.2006.03170.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
374 Georgakis GV, Younes A. Cytokines and lymphomas. Cancer Treat Res 2005;126:69-102. [PMID: 16209063 DOI: 10.1007/0-387-24361-5_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
375 Stohl W, Metyas S, Tan SM, Cheema GS, Oamar B, Xu D, Roschke V, Wu Y, Baker KP, Hilbert DM. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum 2003;48:3475-86. [PMID: 14673998 DOI: 10.1002/art.11354] [Cited by in Crossref: 344] [Cited by in F6Publishing: 309] [Article Influence: 20.2] [Reference Citation Analysis]
376 Cabatingan MS, Schmidt MR, Sen R, Woodland RT. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol 2002;169:6795-805. [PMID: 12471111 DOI: 10.4049/jimmunol.169.12.6795] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 3.7] [Reference Citation Analysis]
377 Suzuki K, Setoyama Y, Yoshimoto K, Tsuzaka K, Abe T, Takeuchi T. Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells. Cytokine 2008;44:44-8. [PMID: 18707897 DOI: 10.1016/j.cyto.2008.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
378 Hegazy M, Darwish H, Darweesh H, El-shehaby A, Emad Y. Raised serum level of APRIL in patients with systemic lupus erythematosus: Correlations with disease activity indices. Clinical Immunology 2010;135:118-24. [DOI: 10.1016/j.clim.2009.12.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
379 Du SW, Jacobs HM, Arkatkar T, Rawlings DJ, Jackson SW. Integrated B Cell, Toll-like, and BAFF Receptor Signals Promote Autoantibody Production by Transitional B Cells. J Immunol 2018;201:3258-68. [PMID: 30373855 DOI: 10.4049/jimmunol.1800393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
380 Stohl W, Banfalvi A. B cell-independent contribution of BAFF to murine autoimmune disease. Clinical Immunology 2016;172:111-6. [DOI: 10.1016/j.clim.2016.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
381 Wu M, Xu L, Zhai Z, Shu H. SINK Is a p65-interacting Negative Regulator of NF-κB-dependent Transcription. Journal of Biological Chemistry 2003;278:27072-9. [DOI: 10.1074/jbc.m209814200] [Cited by in Crossref: 84] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
382 Karnell JL, Ettinger R. The Interplay of IL-21 and BAFF in the Formation and Maintenance of Human B Cell Memory. Front Immunol 2012;3:2. [PMID: 22566888 DOI: 10.3389/fimmu.2012.00002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
383 Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004;173:2331-41. [PMID: 15294946 DOI: 10.4049/jimmunol.173.4.2331] [Cited by in Crossref: 189] [Cited by in F6Publishing: 176] [Article Influence: 11.1] [Reference Citation Analysis]
384 Hartung HP. [Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis]. Nervenarzt 2009;80:1462-72. [PMID: 19779889 DOI: 10.1007/s00115-009-2838-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
385 Vaux DL. The buzz about BAFF. J Clin Invest 2002;109:17-8. [DOI: 10.1172/jci0214780] [Cited by in Crossref: 13] [Article Influence: 0.7] [Reference Citation Analysis]
386 Danilenko DM, Wang H. The yin and yang of immunomodulatory biologics: assessing the delicate balance between benefit and risk. Toxicol Pathol 2012;40:272-87. [PMID: 22222884 DOI: 10.1177/0192623311430237] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
387 Liu W, Szalai A, Zhao L, Liu D, Martin F, Kimberly RP, Zhou T, Carter RH. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Arthritis Rheum. 2004;50:1884-1896. [PMID: 15188365 DOI: 10.1002/art.20290] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
388 Goenka R, Scholz JL, Sindhava VJ, Cancro MP. New roles for the BLyS/BAFF family in antigen-experienced B cell niches. Cytokine Growth Factor Rev 2014;25:107-13. [PMID: 24507939 DOI: 10.1016/j.cytogfr.2014.01.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
389 Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8. [PMID: 15701725 DOI: 10.1182/blood-2004-11-4284] [Cited by in Crossref: 405] [Cited by in F6Publishing: 370] [Article Influence: 25.3] [Reference Citation Analysis]
390 Li YJ, Jiang WQ, Rao HL, Huang JJ, Xia Y, Huang HQ, Lin TY, Xia ZJ, Li S, Li ZM. Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes. PLoS One 2012;7:e50936. [PMID: 23272079 DOI: 10.1371/journal.pone.0050936] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
391 Qu Z, Qing G, Rabson A, Xiao G. Tax deregulation of NF-kappaB2 p100 processing involves both beta-TrCP-dependent and -independent mechanisms. J Biol Chem. 2004;279:44563-44572. [PMID: 15310758 DOI: 10.1074/jbc.m403689200] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
392 De Silva NS, Silva K, Anderson MM, Bhagat G, Klein U. Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells. J Immunol 2016;196:2591-601. [PMID: 26851215 DOI: 10.4049/jimmunol.1501120] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
393 Cerutti A, Chen K. Role of BAFF and APRIL in Antibody Production and Diversification. In: Cancro MP, editor. BLyS Ligands and Receptors. Totowa: Humana Press; 2010. pp. 65-92. [DOI: 10.1007/978-1-60327-013-7_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
394 Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner QG, Cachero TG, Qiang F, Gorelik L, Kalled SL, Acha-Orbea H, Rennert PD, Tschopp J, Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 2005;201:1375-83. [PMID: 15851487 DOI: 10.1084/jem.20042309] [Cited by in Crossref: 250] [Cited by in F6Publishing: 221] [Article Influence: 15.6] [Reference Citation Analysis]
395 Kimberley FC, Hahne M, Medema JP. "APRIL hath put a spring of youth in everything": Relevance of APRIL for survival. J Cell Physiol 2009;218:1-8. [PMID: 18726990 DOI: 10.1002/jcp.21561] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
396 Meng F, Sun Y, Xu T. Comparative genomic of the BAFF and BAFF-like genes and immune response to bacteria of miiuy croaker (Miichthys miiuy). Fish Shellfish Immunol 2015;43:191-9. [PMID: 25542380 DOI: 10.1016/j.fsi.2014.12.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
397 Van Nieuwenhove E, Barber JS, Neumann J, Smeets E, Willemsen M, Pasciuto E, Prezzemolo T, Lagou V, Seldeslachts L, Malengier-Devlies B, Metzemaekers M, Haßdenteufel S, Kerstens A, van der Kant R, Rousseau F, Schymkowitz J, Di Marino D, Lang S, Zimmermann R, Schlenner S, Munck S, Proost P, Matthys P, Devalck C, Boeckx N, Claessens F, Wouters C, Humblet-Baron S, Meyts I, Liston A. Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia. J Allergy Clin Immunol 2020;146:1180-93. [PMID: 32325141 DOI: 10.1016/j.jaci.2020.03.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
398 Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D, Olsson C, Tom L, Erickson S, French D, Schow P, Grewal IS, Ashkenazi A. APRIL-deficient mice have normal immune system development. Mol Cell Biol 2004;24:997-1006. [PMID: 14729948 DOI: 10.1128/MCB.24.3.997-1006.2004] [Cited by in Crossref: 131] [Cited by in F6Publishing: 40] [Article Influence: 7.7] [Reference Citation Analysis]
399 Yoshimoto K, Tanaka M, Kojima M, Setoyama Y, Kameda H, Suzuki K, Tsuzaka K, Ogawa Y, Tsubota K, Abe T, Takeuchi T. Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome. Arthritis Res Ther 2011;13:R170. [PMID: 22018243 DOI: 10.1186/ar3493] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
400 Zhou J, Rossi JJ, Shum KT. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge. Methods Mol Biol 2015;1297:169-85. [PMID: 25896003 DOI: 10.1007/978-1-4939-2562-9_12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
401 Holl TM, Haynes BF, Kelsoe G. Stromal cell independent B cell development in vitro: generation and recovery of autoreactive clones. J Immunol Methods 2010;354:53-67. [PMID: 20109461 DOI: 10.1016/j.jim.2010.01.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
402 Jellusova J, Miletic AV, Cato MH, Lin WW, Hu Y, Bishop GA, Shlomchik MJ, Rickert RC. Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. Cell Rep 2013;5:1022-35. [PMID: 24239354 DOI: 10.1016/j.celrep.2013.10.022] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
403 Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216-234. [PMID: 15661032 DOI: 10.1111/j.0105-2896.2005.00233.x] [Cited by in Crossref: 139] [Cited by in F6Publishing: 100] [Article Influence: 8.7] [Reference Citation Analysis]
404 Duong BH, Ota T, Aït-Azzouzene D, Aoki-Ota M, Vela JL, Huber C, Walsh K, Gavin AL, Nemazee D. Peripheral B cell tolerance and function in transgenic mice expressing an IgD superantigen. J Immunol 2010;184:4143-58. [PMID: 20231687 DOI: 10.4049/jimmunol.0903564] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
405 Qu Z, Xiao G. Systematic Detection of Noncanonical NF-κB Activation. In: May MJ, editor. NF-kappa B. New York: Springer; 2015. pp. 121-54. [DOI: 10.1007/978-1-4939-2422-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
406 Mayne CG, Nashold FE, Sasaki Y, Hayes CE. Altered BAFF-receptor signaling and additional modifier loci contribute to systemic autoimmunity in A/WySnJ mice. Eur J Immunol 2009;39:589-99. [PMID: 19152335 DOI: 10.1002/eji.200838569] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
407 Li Y, Li Z, Xia Z, Li S, Xia Y, Huang H, Huang J, Yi P, Jiang W. High APRIL but not BAFF serum levels are associated with poor outcome in patients with follicular lymphoma. Ann Hematol 2015;94:79-88. [DOI: 10.1007/s00277-014-2173-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
408 Alexaki VI, Notas G, Pelekanou V, Kampa M, Valkanou M, Theodoropoulos P, Stathopoulos EN, Tsapis A, Castanas E. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 2009;183:5948-56. [PMID: 19828625 DOI: 10.4049/jimmunol.0901186] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.0] [Reference Citation Analysis]
409 La Cava A. Targeting the BLyS-APRIL signaling pathway in SLE. Clin Immunol 2013;148:322-7. [PMID: 23269199 DOI: 10.1016/j.clim.2012.11.010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
410 Cai X, Du J, Liu Y, Xia W, Liu J, Zou M, Wang Y, Wang M, Su H, Xu D. Identification and characterization of receptor-interacting protein 2 as a TNFR-associated factor 3 binding partner. Gene 2013;517:205-11. [DOI: 10.1016/j.gene.2012.12.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
411 Chae SC, Yu JI, Uhm TB, Lee SY, Kang DB, Lee JK, Park WC, Yun KJ. The haplotypes of TNFRSF17 polymorphisms are associated with colon cancer in a Korean population. Int J Colorectal Dis 2012;27:701-7. [PMID: 22108903 DOI: 10.1007/s00384-011-1364-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
412 Graves JD, Craxton A, Clark EA. Modulation and function of caspase pathways in B lymphocytes. Immunol Rev 2004;197:129-46. [PMID: 14962192 DOI: 10.1111/j.0105-2896.2004.0110.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
413 Xu HC, Huang J, Khairnar V, Duhan V, Pandyra AA, Grusdat M, Shinde P, McIlwain DR, Maney SK, Gommerman J, Löhning M, Ohashi PS, Mak TW, Pieper K, Sic H, Speletas M, Eibel H, Ware CF, Tumanov AV, Kruglov AA, Nedospasov SA, Häussinger D, Recher M, Lang KS, Lang PA. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection. J Virol 2015;89:4748-59. [PMID: 25673724 DOI: 10.1128/JVI.02976-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
414 Jiang C, Loo WM, Greenley EJ, Tung KS, Erickson LD. B cell maturation antigen deficiency exacerbates lymphoproliferation and autoimmunity in murine lupus. J Immunol 2011;186:6136-47. [PMID: 21536804 DOI: 10.4049/jimmunol.1001931] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
415 Stohl W. Systemic lupus erythematosus: a blissless disease of too much BLyS (B lymphocyte stimulator) protein: . Current Opinion in Rheumatology 2002;14:522-8. [DOI: 10.1097/00002281-200209000-00007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
416 Madhuranga W, Tharuka MN, Yang H, Lim C, Wan Q, Bathige S, Lee J. Molecular expression analysis and characterization of rockfish (Sebastes schlegelii) B cell activating factor. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2020;250:110480. [DOI: 10.1016/j.cbpb.2020.110480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
417 Rockel JS, Kapoor M. Autophagy: controlling cell fate in rheumatic diseases. Nat Rev Rheumatol 2016;12:517-31. [DOI: 10.1038/nrrheum.2016.92] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 12.8] [Reference Citation Analysis]
418 Mariño E, Walters SN, Villanueva JE, Richards JL, Mackay CR, Grey ST. BAFF regulates activation of self-reactive T cells through B-cell dependent mechanisms and mediates protection in NOD mice. Eur J Immunol 2014;44:983-93. [PMID: 24435807 DOI: 10.1002/eji.201344186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
419 Xiao W, Long W, Liu G, Sui C, Guo X, Tian A, Ji C, Cui X, Zhang S. Molecular cloning, expression and functional analysis of B-cell activating factor (BAFF) in yellow grouper, Epinephelus awoara. Molecular Immunology 2014;59:64-70. [DOI: 10.1016/j.molimm.2014.01.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
420 van der Horst HJ, Nijhof IS, Mutis T, Chamuleau MED. Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies. Cancers (Basel) 2020;12:E3041. [PMID: 33086644 DOI: 10.3390/cancers12103041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
421 Buch MH, Emery P. New therapies in the management of rheumatoid arthritis. Current Opinion in Rheumatology 2011;23:245-51. [DOI: 10.1097/bor.0b013e3283454124] [Cited by in Crossref: 56] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
422 Ferrer G, Bosch R, Hodgson K, Tejero R, Roué G, Colomer D, Montserrat E, Moreno C. B cell activation through CD40 and IL4R ligation modulates the response of chronic lymphocytic leukaemia cells to BAFF and APRIL. Br J Haematol 2014;164:570-8. [PMID: 24245956 DOI: 10.1111/bjh.12645] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
423 Zhou X, Mulazzani M, von Mücke-Heim IA, Langer S, Zhang W, Ishikawa-Ankerhold H, Dreyling M, Straube A, von Baumgarten L. The Role of BAFF-R Signaling in the Growth of Primary Central Nervous System Lymphoma. Front Oncol 2020;10:682. [PMID: 32528875 DOI: 10.3389/fonc.2020.00682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
424 Xu S, Huo J, Chew W, Hikida M, Kurosaki T, Lam K. Phospholipase Cγ2 Dosage Is Critical for B Cell Development in the Absence of Adaptor Protein BLNK. J Immunol 2006;176:4690-8. [DOI: 10.4049/jimmunol.176.8.4690] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
425 Chu VT, Berek C. The establishment of the plasma cell survival niche in the bone marrow. Immunol Rev 2013;251:177-88. [DOI: 10.1111/imr.12011] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 12.4] [Reference Citation Analysis]
426 Andersson S, Nilsson K, Fagerberg L, Hallström BM, Sundström C, Danielsson A, Edlund K, Uhlen M, Asplund A. The transcriptomic and proteomic landscapes of bone marrow and secondary lymphoid tissues. PLoS One 2014;9:e115911. [PMID: 25541736 DOI: 10.1371/journal.pone.0115911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
427 Stohl W. A therapeutic role for BLyS antagonists. Lupus 2004;13:317-22. [DOI: 10.1191/0961203304lu1019oa] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
428 Thangarajh M, Masterman T, Hillert J, Moerk S, Jonsson R. A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis. Scand J Immunol 2007;65:92-8. [PMID: 17212772 DOI: 10.1111/j.1365-3083.2006.01867.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
429 Xu J, Luo X, Qu S, Yang G, Shen N. B cell activation factor (BAFF) induces inflammation in the human fallopian tube leading to tubal pregnancy. BMC Pregnancy Childbirth 2019;19:169. [PMID: 31088412 DOI: 10.1186/s12884-019-2324-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
430 Smith SH, Cancro MP. Cutting edge: B cell receptor signals regulate BLyS receptor levels in mature B cells and their immediate progenitors. J Immunol 2003;170:5820-3. [PMID: 12794106 DOI: 10.4049/jimmunol.170.12.5820] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 6.0] [Reference Citation Analysis]
431 Novak AJ, Darce JR, Arendt BK, Harder B, Henderson K, Kindsvogel W, Gross JA, Greipp PR, Jelinek DF. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004;103:689-94. [PMID: 14512299 DOI: 10.1182/blood-2003-06-2043] [Cited by in Crossref: 333] [Cited by in F6Publishing: 288] [Article Influence: 18.5] [Reference Citation Analysis]
432 Notas G, Alexaki VI, Kampa M, Pelekanou V, Charalampopoulos I, Sabour-Alaoui S, Pediaditakis I, Dessirier V, Gravanis A, Stathopoulos EN, Tsapis A, Castanas E. APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest in liver cells. J Immunol 2012;189:4748-58. [PMID: 23071284 DOI: 10.4049/jimmunol.1102891] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
433 So T, Lee S, Croft M. Tumor Necrosis Factor/Tumor Necrosis Factor Receptor Family Members That Positively Regulate Immunity. International Journal of Hematology 2006;83:1-11. [DOI: 10.1532/ijh97.05120] [Cited by in Crossref: 62] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
434 Emmerich F, Bal G, Barakat A, Milz J, Mühle C, Martinez-Gamboa L, Dörner T, Salama A. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Br J Haematol. 2007;136:309-314. [PMID: 17156395 DOI: 10.1111/j.1365-2141.2006.06431.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
435 Mak TW, Yeh WC. Signaling for survival and apoptosis in the immune system. Arthritis Res 2002;4 Suppl 3:S243-52. [PMID: 12110144 DOI: 10.1186/ar569] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 4.1] [Reference Citation Analysis]
436 Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends in Immunology 2002;23:113-5. [DOI: 10.1016/s1471-4906(01)02159-7] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
437 Dörner T, Kinnman N, Tak PP. Targeting B cells in immune-mediated inflammatory disease: a comprehensive review of mechanisms of action and identification of biomarkers. Pharmacol Ther 2010;125:464-75. [PMID: 20097226 DOI: 10.1016/j.pharmthera.2010.01.001] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
438 Fragioudaki M, Tsirakis G, Pappa CA, Aristeidou I, Tsioutis C, Alegakis A, Kyriakou DS, Stathopoulos EN, Alexandrakis MG. Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma. Leuk Res 2012;36:1004-8. [PMID: 22498341 DOI: 10.1016/j.leukres.2012.03.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
439 Yuan H, Wang Y, Wu X, Wang H, Pu J, Ding W, Wang M, Shen X, Cong H, Zhang L, Zhang M, Ju S. Characterization of the 5'-flanking region and regulation of transcription of human BAFF-R gene. DNA Cell Biol 2010;29:133-9. [PMID: 20025535 DOI: 10.1089/dna.2009.0927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
440 Simenson K, Õiglane-Shlik E, Teek R, Kuuse K, Õunap K. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region. Am J Med Genet A 2014;164A:806-9. [PMID: 24375995 DOI: 10.1002/ajmg.a.36358] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
441 Jacobs HM, Arkatkar T, Du SW, Scharping NE, Woods J, Li QZ, Hudkins KL, Alpers CE, Rawlings DJ, Jackson SW. TACI haploinsufficiency protects against BAFF-driven humoral autoimmunity in mice. Eur J Immunol 2021;51:2225-36. [PMID: 34146342 DOI: 10.1002/eji.202149244] [Reference Citation Analysis]
442 Sun J, Feng J, Li Y, Shen B. A novel BLyS antagonist peptide designed based on the 3-D complex structure of BCMA and BLyS. Biochemical and Biophysical Research Communications 2006;346:1158-62. [DOI: 10.1016/j.bbrc.2006.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
443 Schrezenmeier E, Jayne D, Dörner T. Targeting B Cells and Plasma Cells in Glomerular Diseases: Translational Perspectives. J Am Soc Nephrol 2018;29:741-58. [PMID: 29326157 DOI: 10.1681/ASN.2017040367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 6.7] [Reference Citation Analysis]
444 van Zelm MC, Berkowska MA, van der Burg M, van Dongen JJ. Real-time quantitative (RQ-)PCR approach to quantify the contribution of proliferation to B lymphocyte homeostasis. Methods Mol Biol 2013;979:133-45. [PMID: 23397393 DOI: 10.1007/978-1-62703-290-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
445 Kim KS, Park JY, Jou I, Park SM. Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia. J Leukoc Biol 2009;86:349-59. [PMID: 19406831 DOI: 10.1189/jlb.1008659] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
446 Shen Y, You F, Li C, He Z, Liang Z, Ai H, Wang S, Zhang S. Molecular cloning, bioinformatics analysis and functional characterization of B-cell activating factor in goat (Capra hircus). Dev Comp Immunol 2012;36:191-8. [PMID: 21801746 DOI: 10.1016/j.dci.2011.07.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
447 Zhou B, Zhang H, Su X, Luo Y, Li X, Yu C, Xie Q, Xia X, He G, Yang L. Therapeutic effects of a novel BAFF blocker on arthritis. Signal Transduct Target Ther 2019;4:19. [PMID: 31231554 DOI: 10.1038/s41392-019-0051-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
448 Kim J, Gross JA, Dillon SR, Min J, Elkon KB. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 2011;44:69-81. [DOI: 10.3109/08916934.2010.509122] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
449 Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev 2005;204:43-54. [PMID: 15790349 DOI: 10.1111/j.0105-2896.2005.00219.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
450 Drayton DL, Bonizzi G, Ying X, Liao S, Karin M, Ruddle NH. I kappa B kinase complex alpha kinase activity controls chemokine and high endothelial venule gene expression in lymph nodes and nasal-associated lymphoid tissue. J Immunol 2004;173:6161-8. [PMID: 15528353 DOI: 10.4049/jimmunol.173.10.6161] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
451 Secreto F, Manske M, Price-Troska T, Ziesmer S, Hodge LS, Ansell SM, Cerhan JR, Novak AJ. B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells. Leuk Lymphoma 2014;55:1884-92. [PMID: 24206092 DOI: 10.3109/10428194.2013.862619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
452 Goenka R, Matthews AH, Zhang B, O'Neill PJ, Scholz JL, Migone TS, Leonard WJ, Stohl W, Hershberg U, Cancro MP. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation. J Exp Med 2014;211:45-56. [PMID: 24367004 DOI: 10.1084/jem.20130505] [Cited by in Crossref: 83] [Cited by in F6Publishing: 75] [Article Influence: 10.4] [Reference Citation Analysis]
453 Shinners NP, Carlesso G, Castro I, Hoek KL, Corn RA, Woodland RL, Scott ML, Wang D, Khan WN. Bruton’s Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family. J Immunol 2007;179:3872-80. [DOI: 10.4049/jimmunol.179.6.3872] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
454 Salzer U, Chapel HM, Webster AD, Pan-Hammarström Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schäffer AA. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 2005;37:820-828. [PMID: 16007087 DOI: 10.1038/ng1600] [Cited by in Crossref: 475] [Cited by in F6Publishing: 387] [Article Influence: 29.7] [Reference Citation Analysis]
455 Moscat J, Diaz-Meco MT, Rennert P. NF-kappaB activation by protein kinase C isoforms and B-cell function. EMBO Rep 2003;4:31-6. [PMID: 12524517 DOI: 10.1038/sj.embor.embor704] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 5.0] [Reference Citation Analysis]
456 Illes A, Varoczy L, Papp G, Wilson PC, Alex P, Jonsson R, Kovacs T, Konttinen YT, Zeher M, Nakken B, Szodoray P. Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy. Scand J Immunol 2009;69:387-400. [PMID: 19508370 DOI: 10.1111/j.1365-3083.2009.02237.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
457 Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med. 2005;201:35-39. [PMID: 15630136 DOI: 10.1084/jem.20032000] [Cited by in Crossref: 379] [Cited by in F6Publishing: 344] [Article Influence: 23.7] [Reference Citation Analysis]
458 Sun Y, Sun L. CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity. PLoS One 2015;10:e0136015. [PMID: 26295165 DOI: 10.1371/journal.pone.0136015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
459 Soleto I, Abós B, Castro R, González L, Tafalla C, Granja AG. The BAFF / APRIL axis plays an important role in virus-induced peritoneal responses in rainbow trout. Fish Shellfish Immunol 2017;64:210-7. [PMID: 28302579 DOI: 10.1016/j.fsi.2017.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
460 Wang D, Chang Y, Wu Y, Zhang L, Yan S, Xie G, Qin Q, Jin J, Wang W, Fang J, Wei W. Therapeutic effects of TACI-Ig on rat with adjuvant arthritis. Clin Exp Immunol 2011;163:225-34. [PMID: 21155990 DOI: 10.1111/j.1365-2249.2010.04293.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
461 McCarthy DD, Chiu S, Gao Y, Summers-deLuca LE, Gommerman JL. BAFF induces a hyper-IgA syndrome in the intestinal lamina propria concomitant with IgA deposition in the kidney independent of LIGHT. Cell Immunol 2006;241:85-94. [PMID: 16987502 DOI: 10.1016/j.cellimm.2006.08.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
462 Feigenbaum LZ, Lee D, Ho J. Routine testing of folate levels in geriatric assessment for dementia. J Am Geriatr Soc. 1988;36:755. [PMID: 3136199 DOI: 10.1016/j.cca.2019.07.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
463 Roschke V, Sosnovtseva S, Ward CD, Hong JS, Smith R, Albert V, Stohl W, Baker KP, Ullrich S, Nardelli B, Hilbert DM, Migone TS. BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases. J Immunol 2002;169:4314-21. [PMID: 12370363 DOI: 10.4049/jimmunol.169.8.4314] [Cited by in Crossref: 192] [Cited by in F6Publishing: 172] [Article Influence: 10.1] [Reference Citation Analysis]
464 Proust A, Rincé P, Creidy R, Lazure T, Joab I, Garçon L, Fabre M, Guettier C, Raphael M. p52 Activation in monomorphic B-cell posttransplant lymphoproliferative disorder/diffuse large B-cell lymphoma without BAFF-R expression. Am J Pathol 2011;179:1630-7. [PMID: 21871426 DOI: 10.1016/j.ajpath.2011.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
465 Woess C, Tuzlak S, Labi V, Drach M, Bertele D, Schneider P, Villunger A. Combined loss of the BH3-only proteins Bim and Bmf restores B-cell development and function in TACI-Ig transgenic mice. Cell Death Differ 2015;22:1477-88. [PMID: 25698446 DOI: 10.1038/cdd.2015.8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
466 Pham LV, Fu L, Tamayo AT, Bueso-Ramos C, Drakos E, Vega F, Medeiros LJ, Ford RJ. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways. Blood 2011;117:200-10. [PMID: 20889926 DOI: 10.1182/blood-2010-06-290437] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
467 Monroe JG, Dorshkind K. Fate decisions regulating bone marrow and peripheral B lymphocyte development. Adv Immunol 2007;95:1-50. [PMID: 17869609 DOI: 10.1016/S0065-2776(07)95001-4] [Cited by in Crossref: 81] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
468 Mackay F, Schneider P. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties. Cytokine Growth Factor Rev 2008;19:263-76. [PMID: 18514565 DOI: 10.1016/j.cytogfr.2008.04.006] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 7.3] [Reference Citation Analysis]
469 Koizumi M, Hiasa Y, Kumagi T, Yamanishi H, Azemoto N, Kobata T, Matsuura B, Abe M, Onji M. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. PLoS One. 2013;8:e71367. [PMID: 23940742 DOI: 10.1371/journal.pone.0071367] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
470 Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ. Discovery of high-affinity peptide binders to BLyS by phage display. J Mol Recognit 2005;18:94-102. [DOI: 10.1002/jmr.722] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
471 Hamada M, Abe M, Miyake T, Kawasaki K, Tada F, Furukawa S, Matsuura B, Hiasa Y, Onji M. B cell-activating factor controls the production of adipokines and induces insulin resistance. Obesity (Silver Spring) 2011;19:1915-22. [PMID: 21701571 DOI: 10.1038/oby.2011.165] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
472 Kawasaki K, Abe M, Tada F, Tokumoto Y, Chen S, Miyake T, Furukawa S, Matsuura B, Hiasa Y, Onji M. Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity. Lab Invest 2013;93:311-21. [PMID: 23318884 DOI: 10.1038/labinvest.2012.176] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
473 Kim HM, Yu KS, Lee ME, Shin DR, Kim YS, Paik SG, Yoo OJ, Lee H, Lee JO. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat Struct Biol 2003;10:342-8. [PMID: 12715002 DOI: 10.1038/nsb925] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 3.7] [Reference Citation Analysis]
474 Stohl W. Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2014;18:473-89. [DOI: 10.1517/14728222.2014.888415] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
475 Stohl W, Hilbert DM. The discovery and development of belimumab: the anti-BLyS-lupus connection. Nat Biotechnol 2012;30:69-77. [PMID: 22231104 DOI: 10.1038/nbt.2076] [Cited by in Crossref: 91] [Cited by in F6Publishing: 256] [Article Influence: 10.1] [Reference Citation Analysis]
476 Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, Cai W, Freimuth W; Belimumab Study Group. Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther 2008;10:R109. [PMID: 18786258 DOI: 10.1186/ar2506] [Cited by in Crossref: 175] [Cited by in F6Publishing: 149] [Article Influence: 13.5] [Reference Citation Analysis]
477 Stohl W, Looney RJ. B cell depletion therapy in systemic rheumatic diseases: different strokes for different folks? Clin Immunol 2006;121:1-12. [PMID: 16697258 DOI: 10.1016/j.clim.2006.03.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
478 Swee LK, Tardivel A, Schneider P, Rolink A. Rescue of the mature B cell compartment in BAFF-deficient mice by treatment with recombinant Fc-BAFF. Immunol Lett 2010;131:40-8. [PMID: 20350570 DOI: 10.1016/j.imlet.2010.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
479 Péron S, Pan-Hammarström Q, Imai K, Du L, Taubenheim N, Sanal O, Marodi L, Bergelin-Besançon A, Benkerrou M, de Villartay JP, Fischer A, Revy P, Durandy A. A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair. J Exp Med 2007;204:1207-16. [PMID: 17485519 DOI: 10.1084/jem.20070087] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
480 Haiat S, Billard C, Quiney C, Ajchenbaum-Cymbalista F, Kolb JP. Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia. Immunology 2006;118:281-92. [PMID: 16827889 DOI: 10.1111/j.1365-2567.2006.02377.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 4.8] [Reference Citation Analysis]
481 Ju S, Wang Y, Ni H, Wang X, Jiang P, Kong X, Zhong R. Correlation of expression levels of BLyS and its receptors with multiple myeloma. Clinical Biochemistry 2009;42:387-99. [DOI: 10.1016/j.clinbiochem.2008.10.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
482 Migita K, Ilyassova B, Kovzel EF, Nersesov A, Abiru S, Maeda Y, Komori A, Ito M, Yano K, Yatsuhashi H. Serum BAFF and APRIL levels in patients with PBC. Clin Immunol. 2010;134:217-225. [PMID: 19840904 DOI: 10.1016/j.clim.2009.09.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
483 Sanchez E, Li M, Kitto A, Li J, Wang CS, Kirk DT, Yellin O, Nichols CM, Dreyer MP, Ahles CP, Robinson A, Madden E, Waterman GN, Swift RA, Bonavida B, Boccia R, Vescio RA, Crowley J, Chen H, Berenson JR. Serum B-cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival. Br J Haematol 2012;158:727-38. [PMID: 22804669 DOI: 10.1111/j.1365-2141.2012.09241.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 108] [Article Influence: 13.3] [Reference Citation Analysis]
484 Díaz-Rosales P, Muñoz-Atienza E, Tafalla C. Role of teleost B cells in viral immunity. Fish Shellfish Immunol 2019;86:135-42. [PMID: 30448446 DOI: 10.1016/j.fsi.2018.11.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
485 Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F, Tschopp J. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194:1691-1697. [PMID: 11733583 DOI: 10.1084/jem.194.11.1691] [Cited by in Crossref: 169] [Cited by in F6Publishing: 155] [Article Influence: 8.9] [Reference Citation Analysis]
486 Lugade AA, Bharali DJ, Pradhan V, Elkin G, Mousa SA, Thanavala Y. Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity. Nanomedicine: Nanotechnology, Biology and Medicine 2013;9:923-34. [DOI: 10.1016/j.nano.2013.03.008] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
487 Seshasayee D, Valdez P, Yan M, Dixit VM, Tumas D, Grewal IS. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 2003;18:279-88. [PMID: 12594954 DOI: 10.1016/s1074-7613(03)00025-6] [Cited by in Crossref: 297] [Cited by in F6Publishing: 106] [Article Influence: 16.5] [Reference Citation Analysis]
488 Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD, Na S. Enhanced B cell expansion, survival, and humoral responses by targeting death receptor 6. J Exp Med 2003;197:51-62. [PMID: 12515813 DOI: 10.1084/jem.20020617] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
489 Strasser A, Bouillet P. The control of apoptosis in lymphocyte selection: Strasser & Bouillet · Apoptosis regulation in lymphocyte development. Immunological Reviews 2003;193:82-92. [DOI: 10.1034/j.1600-065x.2003.00036.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
490 Ng LG, Ng CH, Woehl B, Sutherland AP, Huo J, Xu S, Mackay F, Lam KP. BAFF costimulation of Toll-like receptor-activated B-1 cells. Eur J Immunol 2006;36:1837-46. [PMID: 16791880 DOI: 10.1002/eji.200635956] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
491 Shum K, Askanase A. Belimumab and the clinical data. Curr Rheumatol Rep 2012;14:310-7. [PMID: 22614721 DOI: 10.1007/s11926-012-0264-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
492 Picaud S, Fedorov O, Thanasopoulou A, Leonards K, Jones K, Meier J, Olzscha H, Monteiro O, Martin S, Philpott M, Tumber A, Filippakopoulos P, Yapp C, Wells C, Che KH, Bannister A, Robson S, Kumar U, Parr N, Lee K, Lugo D, Jeffrey P, Taylor S, Vecellio ML, Bountra C, Brennan PE, O'Mahony A, Velichko S, Müller S, Hay D, Daniels DL, Urh M, La Thangue NB, Kouzarides T, Prinjha R, Schwaller J, Knapp S. Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy. Cancer Res 2015;75:5106-19. [PMID: 26552700 DOI: 10.1158/0008-5472.CAN-15-0236] [Cited by in Crossref: 148] [Cited by in F6Publishing: 77] [Article Influence: 24.7] [Reference Citation Analysis]
493 Hymowitz SG, Patel DR, Wallweber HJ, Runyon S, Yan M, Yin J, Shriver SK, Gordon NC, Pan B, Skelton NJ, Kelley RF, Starovasnik MA. Structures of APRIL-Receptor Complexes. Journal of Biological Chemistry 2005;280:7218-27. [DOI: 10.1074/jbc.m411714200] [Cited by in Crossref: 120] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
494 Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol 2003;4:780-6. [DOI: 10.1038/ni949] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 2.6] [Reference Citation Analysis]
495 Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004;197:179-91. [PMID: 14962195 DOI: 10.1111/j.0105-2896.2004.0109.x] [Cited by in Crossref: 325] [Cited by in F6Publishing: 295] [Article Influence: 19.1] [Reference Citation Analysis]
496 Miosge LA, Goodnow CC. Genes, pathways and checkpoints in lymphocyte development and homeostasis. Immunol Cell Biol 2005;83:318-35. [DOI: 10.1111/j.1440-1711.2005.01353.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
497 Treml LS, Quinn WJ 3rd, Treml JF, Scholz JL, Cancro MP. Manipulating B cell homeostasis: a key component in the advancement of targeted strategies. Arch Immunol Ther Exp (Warsz) 2008;56:153-64. [PMID: 18512030 DOI: 10.1007/s00005-008-0017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
498 Wise LM, Stohl W. The safety of belimumab for the treatment of systemic lupus erythematosus. Expert Opinion on Drug Safety 2019;18:1133-44. [DOI: 10.1080/14740338.2019.1685978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
499 Martin F, Kearney JF. Marginal-zone B cells. Nat Rev Immunol 2002;2:323-35. [PMID: 12033738 DOI: 10.1038/nri799] [Cited by in Crossref: 602] [Cited by in F6Publishing: 536] [Article Influence: 31.7] [Reference Citation Analysis]
500 Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002;3:958-965. [PMID: 12352969 DOI: 10.1038/ni842] [Cited by in Crossref: 519] [Cited by in F6Publishing: 492] [Article Influence: 27.3] [Reference Citation Analysis]
501 Do RK, Chen-Kiang S. Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev 2002;13:19-25. [PMID: 11750877 DOI: 10.1016/s1359-6101(01)00025-9] [Cited by in Crossref: 62] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
502 Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S. Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 2006;54:192-201. [PMID: 16385515 DOI: 10.1002/art.21526] [Cited by in Crossref: 181] [Cited by in F6Publishing: 158] [Article Influence: 12.1] [Reference Citation Analysis]
503 Seyler TM, Park YW, Takemura S, Bram RJ, Kurtin PJ, Goronzy JJ, Weyand CM. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005;115:3083-92. [PMID: 16239971 DOI: 10.1172/JCI25265] [Cited by in Crossref: 179] [Cited by in F6Publishing: 62] [Article Influence: 11.2] [Reference Citation Analysis]
504 Leibler C, Thiolat A, Elsner RA, El Karoui K, Samson C, Grimbert P. Costimulatory blockade molecules and B-cell-mediated immune response: current knowledge and perspectives. Kidney Int 2019;95:774-86. [PMID: 30711200 DOI: 10.1016/j.kint.2018.10.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
505 Thorn M, Lewis RH, Mumbey-Wafula A, Kantrowitz S, Spatz LA. BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretion. Cell Immunol 2010;261:9-22. [PMID: 19914608 DOI: 10.1016/j.cellimm.2009.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
506 Tafalla C, González L, Castro R, Granja AG. B Cell-Activating Factor Regulates Different Aspects of B Cell Functionality and Is Produced by a Subset of Splenic B Cells in Teleost Fish. Front Immunol 2017;8:295. [PMID: 28360916 DOI: 10.3389/fimmu.2017.00295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
507 Yang MG, Sun L, Han J, Zheng C, Liang H, Zhu J, Jin T. Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis. Mol Brain 2019;12:115. [PMID: 31881915 DOI: 10.1186/s13041-019-0532-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
508 Granja AG, Holland JW, Pignatelli J, Secombes CJ, Tafalla C. Characterization of BAFF and APRIL subfamily receptors in rainbow trout (Oncorhynchus mykiss). Potential role of the BAFF / APRIL axis in the pathogenesis of proliferative kidney disease. PLoS One 2017;12:e0174249. [PMID: 28323891 DOI: 10.1371/journal.pone.0174249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
509 Hasler P, Zouali M. B lymphocytes as therapeutic targets in systemic lupus erythematosus. Expert Opinion on Therapeutic Targets 2006;10:803-15. [DOI: 10.1517/14728222.10.6.803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
510 Pasparakis M, Schmidt-Supprian M, Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med 2002;196:743-52. [PMID: 12235208 DOI: 10.1084/jem.20020907] [Cited by in Crossref: 148] [Cited by in F6Publishing: 136] [Article Influence: 7.8] [Reference Citation Analysis]
511 Darce JR, Arendt BK, Chang SK, Jelinek DF. Divergent effects of BAFF on human memory B cell differentiation into Ig-secreting cells. J Immunol 2007;178:5612-22. [PMID: 17442944 DOI: 10.4049/jimmunol.178.9.5612] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
512 Stohl W. Targeting B lymphocyte stimulator in systemic lupus erythematosus and other autoimmune rheumatic disorders. Expert Opinion on Therapeutic Targets 2005;8:177-89. [DOI: 10.1517/14728222.8.3.177] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
513 Sun M, Chen Z, Wu X, Yu Y, Wang L, Lu A, Zhang G, Li F. The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research. Front Immunol 2021;12:602330. [PMID: 33717084 DOI: 10.3389/fimmu.2021.602330] [Reference Citation Analysis]
514 Zarzycka B, Nicolaes GA, Lutgens E. Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis. Expert Rev Clin Pharmacol 2015;8:297-313. [PMID: 25843158 DOI: 10.1586/17512433.2015.1025052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
515 Durandy A, Revy P, Fischer A. Human models of inherited immunoglobulin class switch recombination and somatic hypermutation defects (hyper-IgM syndromes). Adv Immunol 2004;82:295-330. [PMID: 14975260 DOI: 10.1016/S0065-2776(04)82007-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
516 Jia X, Wei F, Sun X, Chang Y, Xu S, Yang X, Wang C, Wei W. CP-25 attenuates the inflammatory response of fibroblast-like synoviocytes co-cultured with BAFF-activated CD4+ T cells. Journal of Ethnopharmacology 2016;189:194-201. [DOI: 10.1016/j.jep.2016.05.034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
517 Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol 2003;23:317-32. [PMID: 14601641 DOI: 10.1023/a:1025319031417] [Cited by in Crossref: 105] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
518 Finnegan A, Ashaye S, Hamel KM. B effector cells in rheumatoid arthritis and experimental arthritis. Autoimmunity. 2012;45:353-363. [PMID: 22432771 DOI: 10.3109/08916934.2012.665526] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
519 Vaux DL. The buzz about BAFF. J Clin Invest. 2002;109:17-18. [PMID: 11781346 DOI: 10.1172/JCI14780] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
520 Novak AJ, Slager SL, Fredericksen ZS, Wang AH, Manske MM, Ziesmer S, Liebow M, Macon WR, Dillon SR, Witzig TE, Cerhan JR, Ansell SM. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res 2009;69:4217-24. [PMID: 19383901 DOI: 10.1158/0008-5472.CAN-08-4915] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
521 Hentges KE, Yarlagadda SP, Justice MJ. Tnfrsf13c (Baffr) is Mis-expressed in Tumors with Murine Leukemia Virus Insertions at Lvis22. Genomics 2002;80:204-12. [DOI: 10.1006/geno.2002.6812] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
522 Feng B, Cheng S, Pear WS, Liou HC. NF-kB inhibitor blocks B cell development at two checkpoints. Med Immunol 2004;3:1. [PMID: 15050028 DOI: 10.1186/1476-9433-3-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
523 Carter RH, Zhao H, Liu X, Pelletier M, Chatham W, Kimberly R, Zhou T. Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus. Arthritis Rheum 2005;52:3943-54. [PMID: 16320342 DOI: 10.1002/art.21489] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
524 Mackay F, Ambrose C. The TNF family members BAFF and APRIL: the growing complexity. Cytokine & Growth Factor Reviews 2003;14:311-24. [DOI: 10.1016/s1359-6101(03)00023-6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
525 Jani MS, Veetil AT, Krishnan Y. Precision immunomodulation with synthetic nucleic acid technologies. Nat Rev Mater 2019;4:451-8. [DOI: 10.1038/s41578-019-0105-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
526 Lau AWY, Turner VM, Bourne K, Hermes JR, Chan TD, Brink R. BAFFR controls early memory B cell responses but is dispensable for germinal center function. J Exp Med 2021;218:e20191167. [PMID: 33119033 DOI: 10.1084/jem.20191167] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
527 Basu M, Lenka SS, Paichha M, Patel B, Banerjee R, Das S, Jayasankar P, Samanta M. B cell activating factor is induced by toll-like receptor and NOD-like receptor-ligands and plays critical role in IgM synthesis in Labeo rohita. Molecular Immunology 2016;78:9-26. [DOI: 10.1016/j.molimm.2016.08.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
528 Lahiri A, Varin M, Le Pottier L, Pochard P, Bendaoud B, Youinou P, Pers J. Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival. Journal of Autoimmunity 2014;51:30-7. [DOI: 10.1016/j.jaut.2014.02.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
529 Wallweber HJ, Compaan DM, Starovasnik MA, Hymowitz SG. The Crystal Structure of A Proliferation-inducing Ligand, APRIL. Journal of Molecular Biology 2004;343:283-90. [DOI: 10.1016/j.jmb.2004.08.040] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
530 Khan WN. B cell receptor and BAFF receptor signaling regulation of B cell homeostasis. J Immunol 2009;183:3561-7. [PMID: 19726767 DOI: 10.4049/jimmunol.0800933] [Cited by in Crossref: 112] [Cited by in F6Publishing: 110] [Article Influence: 9.3] [Reference Citation Analysis]
531 Laâbi Y, Egle A, Strasser A. TNF cytokine family: more BAFF-ling complexities. Curr Biol 2001;11:R1013-6. [PMID: 11747837 DOI: 10.1016/s0960-9822(01)00613-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
532 Xu LG, Shu HB. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 2002;169:6883-9. [PMID: 12471121 DOI: 10.4049/jimmunol.169.12.6883] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 6.3] [Reference Citation Analysis]
533 Hashiguchi M, Kashiwakura Y, Kanno Y, Kojima H, Kobata T. Tumor necrosis factor superfamily member (TNFSF) 13 (APRIL) and TNFSF13B (BAFF) downregulate homeostatic immunoglobulin production in the intestines. Cellular Immunology 2018;323:41-8. [DOI: 10.1016/j.cellimm.2017.10.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
534 Yeramilli VA, Knight KL. Requirement for BAFF and APRIL during B cell development in GALT. J Immunol 2010;184:5527-36. [PMID: 20400696 DOI: 10.4049/jimmunol.1000146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
535 Jeurissen A, Ceuppens JL, Bossuyt X. T lymphocyte dependence of the antibody response to 'T lymphocyte independent type 2' antigens. Immunology 2004;111:1-7. [PMID: 14678191 DOI: 10.1111/j.1365-2567.2004.01775.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
536 Guadagnoli M, Kimberley FC, Phan U, Cameron K, Vink PM, Rodermond H, Eldering E, Kater AP, van Eenennaam H, Medema JP. Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas. Blood 2011;117:6856-65. [PMID: 21543761 DOI: 10.1182/blood-2011-01-330852] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
537 Halpern WG, Lappin P, Zanardi T, Cai W, Corcoran M, Zhong J, Baker KP. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Toxicol Sci 2006;91:586-99. [PMID: 16517838 DOI: 10.1093/toxsci/kfj148] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 6.4] [Reference Citation Analysis]
538 Vinay DS, Kwon BS. Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 2012;57:305-12. [PMID: 22209079 DOI: 10.1016/j.cyto.2011.12.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
539 Thangarajh M, Gomes A, Masterman T, Hillert J, Hjelmström P. Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosis. J Neuroimmunol 2004;152:183-90. [PMID: 15223251 DOI: 10.1016/j.jneuroim.2004.03.017] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 3.9] [Reference Citation Analysis]
540 Rihacek M, Bienertova-Vasku J, Valik D, Sterba J, Pilatova K, Zdrazilova-Dubska L. B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia. Biomed Res Int 2015;2015:792187. [PMID: 26339644 DOI: 10.1155/2015/792187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
541 Jiang P, Yueguo W, Huiming H, Hongxiang Y, Mei W, Ju S. B-Lymphocyte stimulator: a new biomarker for multiple myeloma. Eur J Haematol 2009;82:267-76. [PMID: 19187273 DOI: 10.1111/j.1600-0609.2008.01203.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
542 Chang Y, Sun X, Jia X, Xu S, Wei F, Yang X, Wei W. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis. International Immunopharmacology 2015;24:451-7. [DOI: 10.1016/j.intimp.2015.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
543 Haselmayer P, Vigolo M, Nys J, Schneider P, Hess H. A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells. Eur J Immunol 2017;47:1075-85. [PMID: 28383107 DOI: 10.1002/eji.201746934] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
544 Lin WY, Gong Q, Seshasayee D, Lin Z, Ou Q, Ye S, Suto E, Shu J, Lee WP, Lee CW, Fuh G, Leabman M, Iyer S, Howell K, Gelzleichter T, Beyer J, Danilenko D, Yeh S, DeForge LE, Ebens A, Thompson JS, Ambrose C, Balazs M, Starovasnik MA, Martin F. Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade. Blood 2007;110:3959-67. [PMID: 17687108 DOI: 10.1182/blood-2007-04-088088] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
545 Park CS, Choi YS. How do follicular dendritic cells interact intimately with B cells in the germinal centre? Immunology 2005;114:2-10. [PMID: 15606789 DOI: 10.1111/j.1365-2567.2004.02075.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 85] [Article Influence: 7.0] [Reference Citation Analysis]
546 Cao P, Zhang S, Fang Z, Huang H, Bai P, Zhang Q, Luo C. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS. Appl Microbiol Biotechnol 2008;78:275-82. [DOI: 10.1007/s00253-007-1299-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
547 Zhou J, Tiemann K, Chomchan P, Alluin J, Swiderski P, Burnett J, Zhang X, Forman S, Chen R, Rossi J. Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Res 2013;41:4266-83. [PMID: 23470998 DOI: 10.1093/nar/gkt125] [Cited by in Crossref: 54] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
548 Lyu MA, Sung B, Cheung LH, Marks JW, Aggarwal BB, Aguiar RC, Rosenblum MG. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma. Biochem Pharmacol 2010;80:1335-42. [PMID: 20654581 DOI: 10.1016/j.bcp.2010.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
549 Matsumoto Y, Kobata T, Odaka M, Furukawa K, Hirata K, Yuki N. BAFF aids generation of IgG anti-ganglioside antibodies in response to Campylobacter jejuni lipo-oligosaccharide. Journal of Neuroimmunology 2010;218:67-72. [DOI: 10.1016/j.jneuroim.2009.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
550 Kyaw T, Tay C, Hosseini H, Kanellakis P, Gadowski T, MacKay F, Tipping P, Bobik A, Toh BH. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One 2012;7:e29371. [PMID: 22238605 DOI: 10.1371/journal.pone.0029371] [Cited by in Crossref: 116] [Cited by in F6Publishing: 106] [Article Influence: 12.9] [Reference Citation Analysis]
551 Tanaka S, Baba Y. B Cell Receptor Signaling. In: Wang J, editor. B Cells in Immunity and Tolerance. Singapore: Springer; 2020. pp. 23-36. [DOI: 10.1007/978-981-15-3532-1_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
552 Kawasaki A, Tsuchiya N, Fukazawa T, Hashimoto H, Tokunaga K. Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis. Genes Immun 2002;3:424-9. [PMID: 12424625 DOI: 10.1038/sj.gene.6363923] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 4.1] [Reference Citation Analysis]
553 Tak PP, Thurlings RM, Rossier C, Nestorov I, Dimic A, Mircetic V, Rischmueller M, Nasonov E, Shmidt E, Emery P, Munafo A. Atacicept in patients with rheumatoid arthritis: Results of a multicenter, phase ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study. Arthritis Rheum 2008;58:61-72. [DOI: 10.1002/art.23178] [Cited by in Crossref: 162] [Cited by in F6Publishing: 147] [Article Influence: 11.6] [Reference Citation Analysis]
554 Zouali M, Uy EA. Belimumab Therapy in Systemic Lupus Erythematosus. BioDrugs 2013;27:225-35. [DOI: 10.1007/s40259-013-0031-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
555 Kaileh M, Sen R. NF-κB function in B lymphocytes: NF-κB function in B lymphocytes. Immunological Reviews 2012;246:254-71. [DOI: 10.1111/j.1600-065x.2012.01106.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
556 Cambridge G, Stohl W, Leandro MJ, Migone TS, Hilbert DM, Edwards JC. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Arthritis Rheum 2006;54:723-32. [PMID: 16508933 DOI: 10.1002/art.21650] [Cited by in Crossref: 187] [Cited by in F6Publishing: 166] [Article Influence: 12.5] [Reference Citation Analysis]
557 Frederico B, May JS, Efstathiou S, Stevenson PG. BAFF receptor deficiency limits gammaherpesvirus infection. J Virol 2014;88:3965-75. [PMID: 24501409 DOI: 10.1128/JVI.03497-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
558 Lee CV, Hymowitz SG, Wallweber HJ, Gordon NC, Billeci KL, Tsai S, Compaan DM, Yin J, Gong Q, Kelley RF, Deforge LE, Martin F, Starovasnik MA, Fuh G. Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 2006;108:3103-11. [DOI: 10.1182/blood-2006-03-011031] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
559 Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA. 2004;101:3903-3908. [PMID: 14988498 DOI: 10.1073/pnas.0307348101] [Cited by in Crossref: 321] [Cited by in F6Publishing: 290] [Article Influence: 18.9] [Reference Citation Analysis]
560 Borhis G, Trovato M, Chaoul N, Ibrahim HM, Richard Y. B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection. Front Immunol 2017;8:1338. [PMID: 29163465 DOI: 10.3389/fimmu.2017.01338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
561 Darce JR, Arendt BK, Wu X, Jelinek DF. Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 2007;179:7276-86. [PMID: 18025170 DOI: 10.4049/jimmunol.179.11.7276] [Cited by in Crossref: 179] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
562 Lemancewicz D, Bolkun L, Jablonska E, Kulczynska A, Bolkun-skornicka U, Kloczko J, Dzieciol J. Evaluation of TNF superfamily molecules in multiple myeloma patients: Correlation with biological and clinical features. Leukemia Research 2013;37:1089-93. [DOI: 10.1016/j.leukres.2013.05.014] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
563 Rahmanzadeh R, Weber MS, Brück W, Navardi S, Sahraian MA. B cells in multiple sclerosis therapy-A comprehensive review. Acta Neurol Scand 2018;137:544-56. [PMID: 29512131 DOI: 10.1111/ane.12915] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
564 Peter HH, Warnatz K. Molecules involved in T-B co-stimulation and B cell homeostasis: possible targets for an immunological intervention in autoimmunity. Expert Opin Biol Ther 2005;5 Suppl 1:S61-71. [PMID: 16187941 DOI: 10.1517/14712598.5.1.s61] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
565 Hu J, Yu Y, Han H, Civoli F, Zhuang Y, Thomas J, Swanson S, Jing S, Gupta S. Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics. Cells 2014;3:79-91. [PMID: 24709903 DOI: 10.3390/cells3010079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
566 Xu X, Sun Q, Liang X, Chen Z, Zhang X, Zhou X, Li M, Tu H, Liu Y, Tu S, Li Y. Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies. Front Immunol 2019;10:2664. [PMID: 31798590 DOI: 10.3389/fimmu.2019.02664] [Cited by in Crossref: 68] [Cited by in F6Publishing: 48] [Article Influence: 34.0] [Reference Citation Analysis]
567 Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003;5 Suppl 4:S22-7. [PMID: 15180894 DOI: 10.1186/ar1009] [Cited by in Crossref: 76] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
568 Lwin T, Crespo LA, Wu A, Dessureault S, Shu HB, Moscinski LC, Sotomayor E, Dalton WS, Tao J. Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin's B lymphoma cells from apoptosis. Leukemia 2009;23:170-7. [PMID: 18843286 DOI: 10.1038/leu.2008.266] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
569 Cariappa A, Pillai S. Antigen-dependent B-cell development. Current Opinion in Immunology 2002;14:241-9. [DOI: 10.1016/s0952-7915(02)00328-x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
570 Kanswal S, Katsenelson N, Selvapandiyan A, Bram RJ, Akkoyunlu M. Deficient TACI expression on B lymphocytes of newborn mice leads to defective Ig secretion in response to BAFF or APRIL. J Immunol 2008;181:976-90. [PMID: 18606649 DOI: 10.4049/jimmunol.181.2.976] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 4.8] [Reference Citation Analysis]
571 Jordan N, D’cruz DP. Belimumab for the treatment of systemic lupus erythematosus. Expert Review of Clinical Immunology 2014;11:195-204. [DOI: 10.1586/1744666x.2015.996550] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
572 Moir S, Malaspina A, Pickeral OK, Donoghue ET, Vasquez J, Miller NJ, Krishnan SR, Planta MA, Turney JF, Justement JS, Kottilil S, Dybul M, Mican JM, Kovacs C, Chun TW, Birse CE, Fauci AS. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 2004;200:587-99. [PMID: 15353552 DOI: 10.1084/jem.20032236] [Cited by in Crossref: 166] [Cited by in F6Publishing: 142] [Article Influence: 9.8] [Reference Citation Analysis]
573 Mcheyzer-williams MG. B cells as effectors. Current Opinion in Immunology 2003;15:354-61. [DOI: 10.1016/s0952-7915(03)00046-3] [Cited by in Crossref: 87] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
574 Mecklenbräuker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCδ-mediated nuclear signalling. Nature 2004;431:456-61. [DOI: 10.1038/nature02955] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 6.7] [Reference Citation Analysis]
575 Estes DM. Regulation of IgA responses in cattle, humans and mice. Vet Immunol Immunopathol. 2010;138:312-317. [PMID: 21074276 DOI: 10.1016/j.vetimm.2010.10.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
576 Lascano V, Zabalegui LF, Cameron K, Guadagnoli M, Jansen M, Burggraaf M, Versloot M, Rodermond H, van der Loos C, Carvalho-Pinto CE, Kalthoff H, Medema JP, Hahne M. The TNF family member APRIL promotes colorectal tumorigenesis. Cell Death Differ 2012;19:1826-35. [PMID: 22705846 DOI: 10.1038/cdd.2012.68] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
577 Elalouf O, Keeling SO, Touma Z. Subcutaneous belimumab in the treatment of systemic lupus erythematosus. Immunotherapy 2018;10:1163-73. [PMID: 30105936 DOI: 10.2217/imt-2018-0061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
578 Zhu K, Feferman T, Maiti PK, Souroujon MC, Fuchs S. Intravenous immunoglobulin suppresses experimental myasthenia gravis: Immunological mechanisms. Journal of Neuroimmunology 2006;176:187-97. [DOI: 10.1016/j.jneuroim.2006.04.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
579 Grammer AC, Lipsky PE. CD154-CD40 interactions mediate differentiation to plasma cells in healthy individuals and persons with systemic lupus erythematosus. Arthritis Rheum 2002;46:1417-29. [PMID: 12115170 DOI: 10.1002/art.10287] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
580 Nimmanapalli R, Lyu MA, Du M, Keating MJ, Rosenblum MG, Gandhi V. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood 2007;109:2557-64. [PMID: 17119117 DOI: 10.1182/blood-2006-08-042424] [Cited by in Crossref: 32] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
581 Huard B, Schneider P, Mauri D, Tschopp J, French LE. T Cell Costimulation by the TNF Ligand BAFF. J Immunol 2001;167:6225-31. [DOI: 10.4049/jimmunol.167.11.6225] [Cited by in Crossref: 166] [Cited by in F6Publishing: 154] [Article Influence: 8.3] [Reference Citation Analysis]
582 Kim HA, Seo GY, Kim PH. Macrophage-derived BAFF induces AID expression through the p38MAPK/CREB and JNK/AP-1 pathways. J Leukoc Biol 2011;89:393-8. [PMID: 21169521 DOI: 10.1189/jlb.1209787] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
583 Stewart DM, Mcavoy MJ, Hilbert DM, Nelson DL. B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro. Clinical Immunology 2003;109:137-43. [DOI: 10.1016/s1521-6616(03)00215-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
584 Patel DR, Wallweber HJ, Yin J, Shriver SK, Marsters SA, Gordon NC, Starovasnik MA, Kelley RF. Engineering an APRIL-specific B Cell Maturation Antigen. Journal of Biological Chemistry 2004;279:16727-35. [DOI: 10.1074/jbc.m312316200] [Cited by in Crossref: 40] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
585 Guo W, Qu X, Yang M, Zhang W, Liang L, Shao Q, Kong B. Expression of BAFF in the trophoblast and decidua of normal early pregnant women and patients with recurrent spontaneous miscarriage: . Chinese Medical Journal 2008;121:309-15. [DOI: 10.1097/00029330-200802020-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
586 Sindhava VJ, Scholz JL, Stohl W, Cancro MP. APRIL mediates peritoneal B-1 cell homeostasis. Immunol Lett 2014;160:120-7. [PMID: 24512739 DOI: 10.1016/j.imlet.2014.01.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
587 Xu W, Banchereau J. The antigen presenting cells instruct plasma cell differentiation. Front Immunol 2014;4:504. [PMID: 24432021 DOI: 10.3389/fimmu.2013.00504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
588 Hehlgans T, Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology. 2005;115:1-20. [PMID: 15819693 DOI: 10.1111/j.1365-2567.2005.02143.x] [Cited by in Crossref: 542] [Cited by in F6Publishing: 470] [Article Influence: 33.9] [Reference Citation Analysis]
589 Pego-Reigosa JM, Isenberg DA. Systemic lupus erythematosus: pharmacological developments and recommendations for a therapeutic strategy. Expert Opin Investig Drugs 2008;17:31-41. [PMID: 18095917 DOI: 10.1517/13543784.17.1.31] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
590 Rossi AP, Alloway RR, Hildeman D, Woodle ES. Plasma cell biology: Foundations for targeted therapeutic development in transplantation. Immunol Rev 2021;303:168-86. [PMID: 34254320 DOI: 10.1111/imr.13011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
591 Sakurai D, Hase H, Kanno Y, Kojima H, Okumura K, Kobata T. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 2007;109:2961-7. [PMID: 17119122 DOI: 10.1182/blood-2006-08-041772] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 6.4] [Reference Citation Analysis]
592 Craxton A, Magaletti D, Ryan EJ, Clark EA. Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood. 2003;101:4464-4471. [PMID: 12531790 DOI: 10.1182/blood-2002-10-3123] [Cited by in Crossref: 229] [Cited by in F6Publishing: 203] [Article Influence: 12.7] [Reference Citation Analysis]
593 Hartung HP, Kieseier BC. Atacicept: targeting B cells in multiple sclerosis. Ther Adv Neurol Disord 2010;3:205-16. [PMID: 21179612 DOI: 10.1177/1756285610371146] [Cited by in Crossref: 89] [Cited by in F6Publishing: 82] [Article Influence: 8.9] [Reference Citation Analysis]
594 Rodig SJ, Shahsafaei A, Li B, Mackay CR, Dorfman DM. BAFF-R, the major B cell-activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders. Hum Pathol 2005;36:1113-9. [PMID: 16226112 DOI: 10.1016/j.humpath.2005.08.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.0] [Reference Citation Analysis]
595 Jackson DA, Smith TD, Amarsaikhan N, Han W, Neil MS, Boi SK, Vrabel AM, Tolosa EJ, Almada LL, Fernandez-Zapico ME, Elsawa SF. Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells. J Immunol 2015;195:2908-16. [PMID: 26238488 DOI: 10.4049/jimmunol.1402974] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
596 Shanahan JC, Moreland LW, Carter RH. Upcoming biologic agents for the treatment of rheumatic diseases: . Current Opinion in Rheumatology 2003;15:226-63. [DOI: 10.1097/00002281-200305000-00009] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]